WorldWideScience

Sample records for salivaires lymphomes sarcomes

  1. sarcome d'ewing

    African Journals Online (AJOL)

    7 mai 2012 ... Le sarcome d'Ewing est une tumeur osseuse rare corres- pondant à la ... Introduction : petrous Ewing sarcoma is exceptional. We report a ..... (15) Iriz A, Albayrak L, Eryilmaz A. Extraskeletal primary Ewing's sarcoma of the.

  2. LYMPHOME T/NK PRIMITIF DU LARYNx : LOCALISATION ...

    African Journals Online (AJOL)

    CONCLUSION. En conclusion le lymphome T/Nk du larynx est une entité rare et extrêmement agressive associée à une forte mor- talité. Malgré que le protocole SMiLE ou d'autres régimes contenant la L-asparaginase sont prometteurs dans ce type de lymphome incurable, d'autres essais thérapeu- tiques sont nécessaires ...

  3. Profil épidémiologique des tumeurs malignes primitives des glandes salivaires : à propos de 154 cas

    Science.gov (United States)

    Setti, Khadija; Mouanis, Mohamed; Moumni, Abdelmounim; Maher, Mostafa; Harmouch, Amal

    2014-01-01

    Introduction Les tumeurs des glandes salivaires sont des tumeurs rares représentant 3à 5% des tumeurs de la tête et du cou. La classification de l'OMS 2005 distingue les tumeurs épithéliales, les tumeurs mésenchymateuses, les tumeurs hématologiques et les tumeurs secondaires. Méthodes Notre travail consiste en une étude rétrospective réalisée sur une période de 10 ans allant de janvier 2002 à janvier 2012. Les critères d'inclusion étaient: l'âge, le sexe, le siège de la tumeur et le type histologique. Résultats L'incidence annuelle des tumeurs malignes primitives des glandes salivaires dans notre série était de 15 cas par an. Cent cinquante quatre cas de tumeurs malignes primitives des glandes salivaires ont été colligés sans prédominance de sexe (78 femmes (50,6%) et 76 hommes (49,4%)). La moyenne d'âge était de 60 ans avec des extrêmes de 4 et 83 ans et un pic de fréquence entre 51et 70 ans. Deux tiers des cas (65%) avaient une localisation au niveau des glandes principales avec 66 cas au niveau de la parotide (43%) et 34 cas au niveau de la glande sous maxillaire (22%). Cinquante quatre patients avaient une tumeur maligne des glandes salivaires accessoires (35%) dont 61% au niveau du palais. Aucun cas de tumeur maligne de la glande sublinguale n'a été recensé dans notre étude. Le type histologique prédominant dans notre série était le carcinome adénoïde kystique et retrouvé chez 43 patients (27,9%), suivi de l'adénocarcinome sans autre indication chez 37 patients (24%) puis du carcinome mucoépidermoïde chez 16 patients (10,4%) et de l'adénocarcinome polymorphe de bas grade également chez 16 patients (10. 4%). Conclusion Les tumeurs malignes des glandes salivaires représentent un ensemble hétérogène de maladies de caractérisation complexe et de fréquence variable. PMID:25120861

  4. B-Zell-Lymphome der Haut - Pathogenese, Diagnostik und Therapie.

    Science.gov (United States)

    Nicolay, Jan P; Wobser, Marion

    2016-12-01

    Primär kutane B-Zell-Lymphome (PCBCL) beschreiben reifzellige lymphoproliferative Erkrankungen der B-Zell-Reihe, die primär die Haut betreffen. Die Biologie und der klinische Verlauf der einzelnen PCBCL-Subtypen variieren untereinander stark und unterscheiden sich grundsätzlich von primär nodalen und systemischen B-Zell-Lymphomen. Primär kutane Marginalzonenlymphome (PCMZL) und primäre kutane follikuläre Keimzentrumslymphome (PCFCL) werden auf Grund ihres unkomplizierten Verlaufs und ihrer exzellenten Prognose zu den indolenten PCBCL gezählt. Demgegenüber stellen die diffus großzelligen B-Zell-Lymphome, hauptsächlich vom Beintyp (DLBCL, LT) die aggressiveren PCBCL-Varianten mit schlechterer Prognose dar. Für die Ausbreitungsdiagnostik und die Therapieentscheidung sind eine genaue histologische und immunhistochemische Klassifizierung sowie der Ausschluss einer systemischen Beteiligung in Abgrenzung zu nodalen oder systemischen Lymphomen notwendig. Die Diagnostik sollte dabei durch molekularbiologische Untersuchungen unterstützt werden. Therapeutisch stehen für die indolenten PCBCL primär operative und radioonkologische Maßnahmen im Vordergrund sowie eine Systemtherapie mit dem CD20-Antikörper Rituximab bei disseminiertem Befall. Die aggressiveren Varianten sollten in erster Linie mit Kombinationen aus Rituximab und Polychemotherapieschemata wie z. B. dem CHOP-Schema oder Modifikationen davon behandelt werden. Auf Grund der in allen seinen Einzelheiten noch nicht vollständig verstandenen Pathogenese und Biologie sowie des begrenzten Therapiespektrums der PCBCL besteht hier, speziell beim DLBCL, LT, noch erheblicher Forschungsbedarf. © 2016 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

  5. Localisation buccale d’un lymphome de Burkitt: à propos d’un cas

    Science.gov (United States)

    Kissi, Lamia; El Bouihi, Rajaa; Lamchahab, Mouna; Alaoui, Ahmed; Benyahya, Ihsane

    2017-01-01

    Le lymphome de Burkitt (LB) est une forme de lymphome malin non-Hodgkinien qui provient de l'évolution maligne et de la prolifération de cellules lymphoïdes de type B. Le diagnostic positif repose sur la biopsie d'une masse tumorale ou la ponction de la moelle osseuse révélant la présence de cellules tumorales. Le cas rapporté est celui d'un jeune homme d'une vingtaine d'années qui a été adressé pour des tuméfactions gingivales évoluant depuis 1 mois suite à des extractions dentaires. L'examen anatomopathologique après biopsie complété par l'immunohistochimie conclut à un lymphome de Burkitt. La prise en charge a consisté en une chimiothérapie. Bien que rare, le lymphome de Burkitt est une tumeur agressive qui représente un véritable problème de santé publique d'où la place importante qu'occupe le médecin dentiste dans le diagnostic précoce afin de permettre une prise en charge rapide et appropriée seule garante de la guérison. PMID:28451040

  6. Lymphome malin non hodgkinien du sein et VIH: à propos d'un cas ...

    African Journals Online (AJOL)

    Le lymphome malin non-hodgkinien (LNH) représente 0,5% de tous les cancers du sein. Son diagnostic est essentiellement histologique. Nous rapportons un cas de LMNH du sein chez une patiente de 42 ans et chez qui la sérologie VIH est positive. L'objectif de cet article est de discuter les aspects cliniques, ...

  7. Medicinal therapy of malignant lymphomas; Medikamentoese Therapie maligner Lymphome

    Energy Technology Data Exchange (ETDEWEB)

    Aul, C.; Schroeder, M.; Giagounidis, A. [Medizinische Klinik II, St.-Johannes-Hospital Duisburg (Germany)

    2002-12-01

    Chemotherapy represents the most important therapeutic option in malignant lymphomas. Low to intermediate risk Hodgkin's disease is treated by a combination of chemotherapy and radiation. The new chemotherapy protocol BEACOPP has improved the outcome of advanced stages in comparison with the internationally accepted standard protocol COPP/ABVD. Dependent on the initial staging, cure rates between 50 and 95% can be achieved. Indolent non-Hodgkin's lymphomas usually present in advanced stages of disease. Chemotherapy in these cases has palliative character and aims at improving patients'quality of life and at avoiding complications due to the disease. In aggressive and very aggressive non-Hodgkin's lymphoma chemotherapy is curative and must be initiated immediately irrespective of the staging results. The efficacy of the standard protocol CHOP (cyclophosphamide,doxorubicin, vincristine and prednisone), that was established in the 1970s, has recently been improved by shortening of the therapy interval (CHOP-14 vs.CHOP-21),addition of etoposide (CHOEP) and combination with the monoclonal antibody rituximab (R-CHOP). The value of high dose chemotherapy with stem cell transplantation has been shown unequivocally only for aggressive non-Hodgkin lymphoma and relapsed Hodgkin's disease responsive to chemotherapy. The therapeutic strategy of malignant lymphomas is likely to be improved within the next years due to the introduction of novel cytostatic agents, the broadening application of monoclonal antibodies,upcoming new transplantation procedures and the development of substances with molecular targets.To rapidly increase our current knowledge on the topic it is mandatory to include patients into the large national and international multicenter studies. (orig.) [German] Die Chemotherapie stellt die wichtigste Behandlungsoption maligner Lymphome dar. Bei Hodgkin-Lymphomen niedrigen bzw. intermediaeren Risikoprofils wird eine kombinierte Behandlung

  8. Spondylodiscite granulomateuse: surtout la tuberculose mais ne pas omettre le lymphome

    Science.gov (United States)

    Zinebi, Ali; Rkiouak, Adil; Akhouad, Yousef; Reggad, Ahmed; Kasmy, Zohour; Boudlal, Mostafa; Lho, Abdelhamid Nait; Rabhi, Moncef; Sinaa, Mohamed; Ennibi, Khalid; Chaari, Jilali

    2016-01-01

    Les douleurs lombaires relèvent d'étiologies multiples dont le diagnostic peut être source de grandes difficultés. Le lymphome rachidien primitif est rare et son diagnostic nécessite une biopsie souvent scanoguidée. Un homme de 30 ans, était hospitalisé pour lombalgies inflammatoires évoluant dans un contexte d'altération de l'état général avec à l'examen des douleurs à la palpation des apophyses épineux L2L3, sans syndrome tumoral périphérique. Le bilan biologique montrait un syndrome inflammatoire. Le bilan morphologique était en faveur d'une spondylodiscite. La première biopsie montrait une ostéite granulomateuse. L'aggravation clinique et radiologique sous anti bacillaire a mené à reconsidérer le diagnostic et la deuxième biopsie confirme le diagnostic du lymphome. Le diagnostic de tuberculose osseuse en particulier vertébrale nécessite une confirmation bactériologique et ou histologique pour ne pas méconnaître un lymphome osseux primitif. PMID:28292061

  9. Value of CT-guided biopsy in malignant lymphoma; Wertigkeit der CT-gesteuerten Biopsie maligner Lymphome

    Energy Technology Data Exchange (ETDEWEB)

    Libicher, M.; Noeldge, G.; Radeleff, B.; Gholipur, F.; Richter, G.M. [Abteilung Radiodiagnostik, Universitaetsklinikum Heidelberg (Germany)

    2002-12-01

    Management of diagnosing malignant lymphomas has changed with development of CT-guided techniques and reliable biopsy tools.Pathologists can use representative tissue samples for sub classification in more than 90%.Evaluation of residual lymphoma or relapse can be nearly as effective. Therefore percutaneous biopsy can be considered as primary diagnostic tool in the absence of peripheral lymphadenopathy. CT-guided biopsies can be performed on an outpatient basis under conscious sedation considering contraindications as well as regional complications. Acceptance of percutaneous biopsy by the pathologist and oncologist is based on diagnostic effectiveness that is significantly improved if more than 3{dagger}solid tissue samples are taken. This article reviews the value of CT-guided biopsy in comparison to surgical procedures in patients with malignant lymphoma. Essential aspects that lead to a diagnostic percutaneous biopsy are discussed on grounds of the current literature. (orig.) [German] Mit der Entwicklung CT-gesteuerter Biopsieverfahren sowie zuverlaessiger Biopsiesysteme hat sich die Vorgehensweise bei der Diagnostik maligner Lymphome geaendert. Repraesentative Stanzzylinder mit hoher Praeparatequalitaet ermoeglichen dem Pathologen eine Subklassifikation der Lymphome in ueber 90%. Eine aehnlich hohe Treffsicherheit ist auch bei der Rezidivdiagnostik moeglich. Deshalb sind perkutane Biopsien bei fehlender peripherer Lymphadenopathie als primaere diagnostische Methode geeignet. Unter Beachtung der Kontraindikationen sowie der regional unterschiedlichen Komplikationsmoeglichkeiten koennen die meisten CT-gesteuerten Biopsien ambulant unter Analgosedierung durchgefuehrt werden. Die Akzeptanz perkutaner Biopsien durch Pathologen und Onkologen ist an die diagnostische Genauigkeit gekoppelt. Diese wird durch Gewinnung von mindestens 3 repraesentativen Biopsiezylindern aus den soliden Anteilen eines Lymphoms signifikant erhoeht. Die vorliegende Uebersichtsarbeit

  10. Sarcome à cellules claires du rein : À propos d’un cas chez un jeune de 17 ans

    Science.gov (United States)

    Mazdar, Adil; Sakel, Adil Ait; Essatara, Younes; Beddouche, Ali; Elsayegh, Hachem; Iken, Ali; Benslimane, Lounis; Nouini, Yassine

    2014-01-01

    Résumé Le sarcome à cellules claires du rein (SCCR) se voit très rarement chez les jeunes. Il est caractérisé par une évolution agressive marquée par un taux élevé de récidive et de mortalité. Nous rapportons le cas d’un SCCR chez un patient de 17 ans et nous discutons de son apport et de son intérêt médical en vue d’une bonne prise en charge thérapeutique. L’agressivité du SCCR et la prolifération de métastases surtout osseuses impliquent qu’il ne faut pas méconnaître ce diagnostic afin de mettre en place un traitement adapté. PMID:24940474

  11. Miocardiopatia hipertrófica não sarcomérica : casos clínicos

    OpenAIRE

    Azevedo, Pedro Miguel Cacais Rua

    2017-01-01

    Trabalho Final do Curso de Mestrado Integrado em Medicina, Faculdade de Medicina, Universidade de Lisboa, 2017 A miocardiopatia hipertrófica é uma patologia em que há hipertrofia miocárdica não causada por patologia hipertensiva, valvular ou outras situações que decorrem com aumento de pós-carga. A miocardiopatia hipertrófica não sarcomérica, tratada neste trabalho, não é causada por mutações em proteínas do sarcómero. Uma das causas da miocardiopatia hipertrófica é a doença de Fabry, d...

  12. Epanchement pleuro-péricardique liquidien révélant un lymphome lymphoblastique

    Science.gov (United States)

    N'goran, Yves N'da Kouakou; Soya, Kossa Esaïe; Beossin, Sylvanus Koui; Angoran, Ines; Traore, Fatou; Tano, Micesse; Afassinou, Yaovi; Ekou, Arnaud; Koffi, Florent; Yao, Hermann; Kramoh, Euloge Kouadio; Kakou, Maurice Guikahue

    2014-01-01

    L'atteinte cardiaque au cours des lymphomes lymphoblastiques est rare. Il s'agissait d'un patient de 17 ans de race noire qui a été admis pour une douleur médiothoracique. Le patient avait des signes d'insuffisance cardiaque droite; un syndrome d’épanchement pleural liquidien gauche; des adénopathies superficielles et une splénomégalie de type IV de Hackett. La biopsie ganglionnaire a été réalisée pour la confirmation du diagnostic par analyse histologique et immuno-histochimique. Des ponctions pleurale et péricardique ont été effectuées. Le patient a été confié au service d'oncologie pédiatrique pour la chimiothérapie. L’évolution a été marquée par le décès du patient 18 jours après. La manifestation cardiaque est une entité rare et très souvent méconnue.la confirmation histologique est parfois difficile à obtenir du vivant de la plupart des patients. Le pronostic est souvent réservé à court terme. PMID:25419294

  13. Intraläsionale Therapie niedrig maligner primär kutaner B-Zell-Lymphome mit Anti-CD20-Antikörper: Nebenwirkungen korrelieren mit gutem klinischen Ansprechen.

    Science.gov (United States)

    Eberle, Franziska C; Holstein, Julia; Scheu, Alexander; Fend, Falko; Yazdi, Amir S

    2017-03-01

    Die intraläsionale Gabe von Anti-CD20-Antikörpern (Rituximab) wurde als effektive Therapieoption für Patienten mit niedrig malignen primär kutanen B-Zell-Lymphomen beschrieben. Bis heute wurden allerdings keine Parameter identifiziert, welche reproduzierbar ein gutes klinisches Ansprechen dieser Therapie vorhersagen. Ziel dieser Studie ist, sowohl das klinische Ansprechen und die unerwünschten Nebenwirkungen als auch die Patientenwahrnehmung hinsichtlich intraläsionaler Injektionen von anti-CD20-Antikörpern zur Behandlung indolenter primär kutaner B-Zell-Lymphome im Vergleich mit anderen Therapien zu evaluieren. Elf Patienten mit einem primär kutanen B-Zell-Lymphom, namentlich primär kutanes Keimzentrumslymphom (n = 9) und primär kutanes Marginalzonenlymphom (n = 2), welche mittels intraläsionalem Anti-CD20-Antikörper behandelt wurden, wurden retrospektiv evaluiert hinsichtlich der Ansprechrate und unerwünschter Nebenwirkungen sowie in Bezug auf deren Selbsteinschätzung dieser und anderer Therapien des primär kutanen B-Zell-Lymphoms. Patienten, deren primär kutanes B-Zell-Lymphom mittels intraläsionaler Gabe von Anti-CD20-Antikörper behandelt wurde, zeigten ein komplettes oder partielles Ansprechen in 45 % beziehungsweise 27 % aller Patienten. Speziell Patienten mit grippeähnlichen Symptomen nach erfolgter Injektion zeigten ein gutes Ansprechen. Die Mehrheit der Patienten empfand die Therapie mit Rituximab als die beste Therapie im Vergleich zu anderen Therapien wie beispielsweise chirurgische Exzision oder Radiotherapie. Intraläsionales Rituximab ist eine effektive Therapie mit hoher Patientenzufriedenheit. Starke therapiebedingte Nebenwirkungen wie Fieber, Schüttelfrost und Kopfschmerzen nach Gabe von Rituximab könnten als Indikator für gute Wirksamkeit dienen. © 2017 Deutsche Dermatologische Gesellschaft (DDG). Published by John Wiley & Sons Ltd.

  14. Mesenteric lymphadenopathy in patient with Yersinia enterocolitica infection. A differential diagnosis to abdominal lymphoma; Mesenteriale Lymphadenopathie bei Infektion mit Yersinia enterocolitica. Eine Differentialdiagnose zum abdominalen Lymphom

    Energy Technology Data Exchange (ETDEWEB)

    Trommer, G.; Koesling, S. [Leipzig Univ. (Germany). Klinik und Poliklinik fuer Diagnostische Radiologie; Bewer, A. [Leipzig Univ. (Germany). Klinik fuer Allgemein-, Thorax- und onkologische Chirurgie

    1998-01-01

    We report a case of previously undiagnosed Yersinia enterocolitica infection in a 46-year old woman. She consulted her physician because of continual weight loss and physical lassitude. A leucocytosis was found. Sonography revealed an excessive enlargement of abdominal lymph nodes. A malignant lymphoma was suspected and the patient underwent a staging by CT. There the disease was limited on mesenteric and retroperitoneal lymph nodes. Bone marrow biopsy and CT-guided lymph node biopsy did not confirm a systemic lymphatic disease. The patient did not undergo a special therapy. After six months, CT showed a clear regression of enlarged lymph nodes. Finally, a previous Yersinia enterocolitica infection of immunotype 03 could be proved serologically. At this time, the patient had no complaints. Diagnostic and differential diagnosis of benign abdominal lymph node enlargement are discussed based on literature. (orig.) [Deutsch] Berichtet wird der Fall einer klinisch inapperenten Yersinia-enterocolitica-Infektion bei einer 46jaehrigen Patientin, die aufgrund stetigen Gewichtsverlustes und koerperlicher Abgeschlagenheit den Hausarzt konsultierte. Dieser diagnostizierte eine Leukozytose. Die daraufhin durchgefuehrte Sonographie ergab eine massive abdominale Lymphknotenvergroesserung. Unter dem Verdacht eines malignen Lymphoms erfolgte eine computertomographische Ausbreitungsdiagnostik, die die Erkrankung auf mesenteriale und retroperitoneale Lymphknoten beschraenkt zeigte. Knochenmarkbiopsie und CT-gestuetzte Lymphknotenpunktion ergaben keinen Hinweis auf eine lymphatische Systemerkrankung. Ohne Therapie zeigte eine CT-Kontrolle nach 6 Monaten eine deutliche Regredienz der Lymphknotenschwellung. Bei der Erregersuche konnte serologisch eine zurueckliegende Infektion mit Yersinia enterocolitica, Serotyp 03, nachgewiesen werden. Zu diesem Zeitpunkt war die Patientin beschwerdefrei. Anhand der Literatur werden Diagnostik und Differentialdiagnose benigner abdominaler

  15. La Malakoplakie Rétropéritonéale Pseudotumorale

    African Journals Online (AJOL)

    mn

    gine tuberculeuse et le syndrome de masse rétropéritonéale, faisant discuter en première intention un sarcome des parties molles ou un lymphome5. Microscopiquement, le gra- nulome malakoplasique est caractérisé par la présence des cellules de Van Hansemann4. Ces cellules sont des histiocytes à larges cy-.

  16. European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte very favorable and favorable, lymphocyte-predominant Hodgkin disease.

    Science.gov (United States)

    Wilder, Richard B; Schlembach, Pamela J; Jones, Dan; Chronowski, Gregory M; Ha, Chul S; Younes, Anas; Hagemeister, Fredrick B; Barista, Ibrahim; Cabanillas, Fernando; Cox, James D

    2002-03-15

    Lymphocyte-predominant Hodgkin disease (LPHD) is rare and has a natural history different from that of classic Hodgkin disease. There is little information in the literature regarding the role of chemotherapy in patients with early-stage LPHD. The objective of this study was to examine recurrence free survival (RFS), overall survival (OS), and patterns of first recurrence in patients with LPHD who were treated with radiotherapy alone or with chemotherapy followed by radiotherapy. From 1963 to 1996, 48 consecutive patients ages 16-49 years (median, 28 years) with Ann Arbor Stage I (n = 30 patients) or Stage II (n = 18 patients), very favorable (VF; n = 5 patients) or favorable (F; n = 43 patients) LPHD, according to the European Organization for Research and Treatment of Cancer and Groupe d'Etude des Lymphomes de l'Adulte (EORTC-GELA) criteria, received radiotherapy alone (n = 37 patients) or received chemotherapy followed by radiotherapy (n = 11 patients). The percentages of patients with VF disease (11% vs. 9% in the radiotherapy group vs. the chemotherapy plus radiotherapy group, respectively) or F disease (89% vs. 91%, respectively) within the two treatment groups were similar (P = 1.00). A median of three cycles of chemotherapy with mechlorethamine, vincristine, procarbazine, and prednisone (MOPP) or with mitoxantrone, vincristine, vinblastine, and prednisone (NOVP) was given initially to six patients and five patients, respectively. A median total radiotherapy dose of 40 grays (Gy) given in daily fractions of 2.0 Gy was delivered to both treatment groups. The median follow-up was 9.3 years, and 98% of patients were observed for > or = 3.0 years. RFS was similar for patients who were treated with radiotherapy alone and patients who were treated with chemotherapy followed by radiotherapy (10-year survival rates: 77% and 68%, respectively; P = 0.89). The OS rate also was similar for the two groups (10-year survival rates: 90% and 100%, respectively; P = 0

  17. Kaposi`s sarcoma; Sarcome de Kaposi

    Energy Technology Data Exchange (ETDEWEB)

    Kirova, Y M; Belembaogo, E; Frikha, H; Yu, S J; Le Bourgeois, J P [Hopital Henri-Mondor, 94 - Creteil (France)

    1997-09-01

    Moriz Kaposi was the first who, in 1872, described five patients presenting with `sarcoma idiopathicum multiple hemorrhagicum`. In 1912 Sternberg termed this disease Kaposi`s sarcoma. Since then various forms of this rare disease have been observed. In 1914 Hallenberg described the first cases of African or endemic Kaposi`s sarcoma. In the 1960`s the first reports discussing Kaposi`s sarcoma following organ transplantation and immunosuppressive therapy were published. After 1981, the epidemic form associated with the acquired immunodeficiency syndrome (AIDS) was described. All these forms, their history, treatment methods and the role of radiation therapy in the management of this rare malignancy are discussed, and the literature is reviewed. (authors)

  18. Case series

    African Journals Online (AJOL)

    ebutamanya

    28 août 2015 ... Les tumeurs de l'enfant sont dominées par les tumeurs du blastème, les lymphomes et les sarcomes. Ces derniers peuvent se présenter sous forme de tumeurs à petites cellules rondes [1]. La biopsie radioguidée percutanée joue un rôle de plus en plus croissant dans le diagnostic et la prise en charge.

  19. MAQUETTE ORL Décembre 2004

    African Journals Online (AJOL)

    rhumatoïde, le syndrome de Gougerot-Sjogren primitif, la sclérodermie ou le lupus, au cours des déficits immuni- taires congénitaux ou acquis, dans le sarcome de Kaposi, dans les adénopathies contiguës à des pathologies malignes notamment les lymphomes ou encore dans des pathologies infectieuses (VIH) (2,3,9).

  20. Application of Tritiated Compounds to the Midge Chironomus and some Aspects of the Metabolism of Salivary Gland Chromosomes; Emploi de Composes Trities pour l'Etude du Chironome et de Certains Aspects du Metabolisme des Chromosomes des Glandes Salivaires; 041f 0440 0438 043c 0414 ; Aplicacion de Compuestos Tritiados a la Mosca Cbironomus y Algunos Aspectos del Metabolismo en los Cromosomas de las Glandulas Salivares

    Energy Technology Data Exchange (ETDEWEB)

    Pelling, C. [Max-Planck-Institut fuer Biologie, Tuebingen, Federal Republic of Germany (Germany)

    1962-02-15

    The investigations were carried out on the salivary gland chromosomes of Chironomus tentons. Tritiated compounds (H{sup 3}-thymidine, H{sup 3}-uridine, H{sup 3}-amino-acids), injected into the haemolymph of the larvae should indicate the place of incorporation within the giant chromosomes. After fixation of the salivary glands autoradiographs of the squash-preparations were made. The autoradiographs show that giant chromosomes are most suitable to localize the activity at chromosomal structures with high resolution. DNA-synthesis (thymidine), RNA-synthesis (uridine) and protein-synthesis within the cell could be followed by determining the time and approximatively the quantity of incorporation: Contrary to the protein-synthesis, the DNA-synthesis and the RNA-synthesis are restricted to the chromosomes. The essential physiological activity of the chromosomes seems to be represented by RNA synthesis which takes place at certain distinct loci (nuceolar organizers, ''Balbiani-rings'', puffs, and other chromosomal bands). The report discusses some features of RNA synthesis. (author) [French] Les recherches ont porte sur les chromosomes des glandes salivaires du chironomus tentans. On a injecte les composes trities (thymidine, uridine, acides amines) dans l'hemolymphe de la larve en vue de determiner le lieu d'incorporation dans les chromosomes geants. Apres fixation par les glandes salivaires, on a procede a des autoradiographies de preparations broyees. Ces autoradiographies montrent que ce sont les chromosomes geants qui permettent le mieux de localiser,- avec une forte resolution, l'activite au niveau chromosomique. L'auteur a pu suivre la synthese de l'ADN (thymidine), la synthese de l'ARN (uridine) et la synthese des proteines a l'interieur de la cellule en determinant le temps et le taux approximatif d'incorporation. A l'inverse de la synthese des proteines, la synthese de l'ADN et celle de l'ARN sont limitees aux chromosomes. L'activite physiologique essentielle

  1. Clinical value of FDG hybrid-PET in staging and restaging of malignant lymphoma. Compared with conventional diagnostic methods; Klinische Wertigkeit der Befunde von FDG-PET mittels Koinzidenz-Gammakamera beim Staging und Restaging maligner Lymphome. Ein Vergleich zu konventioneller Diagnostik

    Energy Technology Data Exchange (ETDEWEB)

    Pichler, R.; Maschek, W.; Hatzl-Griesenhofer, M.; Huber, H. [Allgemeines Krankenhaus Linz (Austria). Inst. fuer Nuklearmedizin; Wimmer, G.; Wahl, G.; Fridrik, M. [Allgemeines Krankenhaus Linz (Austria). I. Medizinische Abt.

    2000-09-01

    Therapieplan. Insgesamt wurden 29 Personen zwecks posttherapeutischem Restaging untersucht. Bei allen wurden Computertomographie- und Lymphknoten-Ultraschalluntersuchungen angewendet. Die Ergebnisse wurden durch den klinischen Verlauf validiert, in drei Faellen wurde ein Rezidiv durch Biopsie bestaetigt. Ergebnisse: CT und US zeigten beim praetherapeutischen Staging 77 Herde verglichen mit 100 durch Doppelkopf-(DK-)PET dargestellten, dieser Unterschied war im Fisher-T-Test jedoch nicht signifikant (p>0,05). Bei der Erkennung residualer Erkrankungsaktivitaet erzielte DK-Koinzidenz-PET eine Sensitivitaet von 93%, eine Spezifitaet von 79%, einen positiven von 82% und einen negativen praediktiven Wert von 92%. Fuer CT+US ergaben sich entsprechend 87%, 64%, 72% und 88%. Schlussfolgerung: FDG-DK-PET erzielt beim Prestaging maligner Lymphome mindestens so genaue Ergebnisse wie ueblicherweise eingesetzte morphologische Diagnoseverfahren. Zusaetzlich ergibt sich ein erkennbarer Vorteil im therapeutischen Monitoring residualer Lymphome durch den Einsatz von Positronen-Koinzidenz-Detektion mittels einer 3/4-Zoll-Kristall-Gammakamera. (orig.)

  2. Localisation inhabituelle du sarcome d'Ewing des parties molles ...

    African Journals Online (AJOL)

    Ewing's sarcoma of soft parts is a rare mesenchymal tumor of poor prognosis. Receiving an early diagnosis increases the chance of survival. In the absence of clinical and radiological features, it seems necessary to include it in the differential diagnosis which includes all the primitive tumour of soft parts and to hypothesize ...

  3. Compression medullaire lente secondaire a un lymphome de Burkitt ...

    African Journals Online (AJOL)

    faciale à la fin du 1er mois et une récupération neurologique au bout d'un an. La localisation secondaire intra rachidienne d'un LB bien que rare doit être présente à l'esprit surtout en face d'une compression médullaire lente survenue dans un ...

  4. Lymphome t/nk primitif du larynx : localisation inhabituelle de ...

    African Journals Online (AJOL)

    The patient was 22-year old male who presented with dysphonia, dyspnea. Chemotherapy protocol SMiLE and radiotherapy were instituted with complete remission of the tumor. Eight months afterward, he presented with tumor recurrence, palpebral edema, obstruction of the lacrymonasal duct. He died within few days with ...

  5. Non-Hodgkin's lymphomas; Lymphomes malins non hodgkiniens

    Energy Technology Data Exchange (ETDEWEB)

    Drouet, F.; Mahe, M.A. [Service de radiotherapie du centre Rene-Gauducheau, CRLCC Nantes-Atlantique, 44 - Saint-Herblain (France); Cahu, X. [Service d' hematologie clinique CHU de Rennes, hopital Pontchaillou, 35 - Rennes (France); Pointreau, Y. [Service de radiotherapie, centre regional universitaire de cancerologie Henry-S.-Kaplan CHU de Tours, Hpital Bretonneau, 37 - Tours (France); Denis, F. [Centre Jean-Bernard, Service de radiotherapie 72 - Le Mans (France)

    2010-07-01

    With approximately 10000 cases per year in France, non-Hodgkin's lymphoma (NHL) represents the most frequent hematological malignancy, and 5 to 10 % of new cases of cancers. NHLs constitute a heterogeneous group of lympho-proliferative diseases, including entities with very different epidemiological and evolutive characteristics, as well as prognosis and treatments. Several classifications exist, but in practice, we individualize aggressive NHL including Diffuse Large B-Cell Lymphomas (DLBCL) which is the most common lymphoma, and indolent NHL including follicular lymphomas and mucosa-associated lymphoid tissue (MALT) lymphomas. The role of the radiotherapy in the management of NHLs varies according to the specific sub-type of lymphoma, but it has become increasingly limited over time. Overall it finds indications with curative intent only in situations of localized LMNH: either associated with chemotherapy as part of a combined modality therapy as for the treatment of localized DLBCL, or as exclusive treatment specially in the rare situations of localized follicular lymphomas. Moreover, lymphocytes being extremely radiosensitive cells, radiotherapy retains excellent indications with palliative intent for the management of symptomatic bulky tumor masses, and that whatever the sub-type of NHLs may be. It is important to remember that even today the 'Involved Field' irradiation type remains the gold standard for the treatment of nodal NHLs, even if we witness at present the emergence of new types of irradiation, which aim to reduce the amount of irradiated tissues to try to limit the risks of delayed radio-induced complications. The purpose of this article is to clarify the specific aspects (epidemiological, radio-anatomical and prognostic characteristics) of each NHLs'sub-types (except primary central nervous system lymphomas), as well as the practical modalities of the irradiation (illustrated by a clinical case record) when an indication of radiotherapy is placed for their treatment. (authors)

  6. Sarcome d'ewing du rocher | Kaffel | Journal Tunisien d'ORL et de ...

    African Journals Online (AJOL)

    Introduction : Primary cranial Ewing's sarcoma is rare. This tumor was first described in 1921, since then, only a few cases have been reported in the literature. Aim: the aim of this study is to report the clinical and therapeutic aspects of primary cranial Ewing's sarcoma. Method: We report a case of Ewing's sarcoma of the ...

  7. Sarcome d'Ewing de localisation pétreuse | Lahiani | Pan African ...

    African Journals Online (AJOL)

    Pan African Medical Journal. Journal Home · ABOUT THIS JOURNAL · Advanced Search · Current Issue · Archives · Journal Home > Vol 22, No 1 (2015) >. Log in or Register to get access to full text downloads. Username, Password, Remember me, or Register · Download this PDF file. The PDF file you selected should ...

  8. Sarcome prostatique : rapport d'un cas et revue de la littérature ...

    African Journals Online (AJOL)

    Prostatic sarcoma is a rare pathologic feature accounting for 0.1-0.2% of prostatic neoplasms. This condition can occur at different ages and there is no clear consensus regarding the treatment. The authors report a case of a giant prostatic sarcoma in a patient aged 62 years old who complains of voiding symptoms and a ...

  9. Sarcome d'Ewing de localisation pétreuse | Lahiani | Pan African ...

    African Journals Online (AJOL)

    La TDM des rochersa révélé un processus tissulaire du conduit auditif externe gauche, étendu à l'oreille moyenne avec lyse du mur de la logette et de l'os temporal. L'IRM des rochers a montré le même processus avec envahissement de la parotide gauche, en hyposignal T1, se réhaussant après injection de gadolinium.

  10. Irradiation of salivary glands in the amyotrophic lateral sclerosis; Irradiation des glandes salivaires dans la sclerose laterale amyotrophique

    Energy Technology Data Exchange (ETDEWEB)

    Bourry, N.; Lapeyre, M.; Tortochaux, J.; Gilliot, O.; Achard, J.L.; Verrelle, P. [Centre Jean-Perrin, Dept. de Radiotherapie 63 - Clermont-Ferrand (France); Clavelou, P.; Rouvet, S. [CHU Gabriel-Montpied, Service de Neurologie, 63 - Clermont-Ferrand (France)

    2006-11-15

    The irradiation of salivary glands in the amyotrophic lateral sclerosis is efficient. A dose about 20 Gy in five seances delivered by electrons seems a correct compromise between efficiency and toxicity. (N.C.)

  11. Le lymphome primitif de la prostate : à propos d'un cas avec revue ...

    African Journals Online (AJOL)

    ra

    Linfoma no-Hodgkin primitivo de glandula prostatica. [Primary non-Hodgkin's lymphoma of the prostate gland]. Arch.Esp.Urol. 1989; Oct;42(8):733-7. Braslis KG, Lee N, Machet D, Peters J. Primary prostatic. 28. lymphoma: A rare prostatic malignancy. Aust.N.Z.J.Surg. 1994; Jan;64(1):58-9. Singh I, Joshi M, Agarwal S, Singh ...

  12. Lymphome B à grandes cellules primitif du médiastin chez la femme ...

    African Journals Online (AJOL)

    Les patientes ont été adressées à l'institut national d'oncologie pour prise en charge thérapeutique. Le pronostic du LBPM est réservé, il survient volontiers chez des femmes jeunes, ce qui rend d'autant plus nécessaire une thérapeutique agressive afin d'améliorer le taux de survie. The Pan African Medical Journal 2016; ...

  13. Postoperative radiotherapy of uterine sarcoma: A multicentric retrospective study; Radiotherapie postoperatoire dans les sarcomes uterins: etude retrospective multicentrique

    Energy Technology Data Exchange (ETDEWEB)

    Champetier, C.; Cowen, D. [Service de radiotherapie, hopital de la Timone, 264, rue Saint-Pierre, 13385 Marseille cedex 05 (France); Hannoun-Levi, J.M. [Centre Antoine-Lacassagne, 33, avenue Valombrose, 06100 Nice (France); Resbeut, M. [Centre de radiotherapie Saint-Louis, rue Andre-Blondel, 83100 Toulon (France); Azria, D. [Centre Val-d' Aurelle-Paul-Lamarque, 208, rue des Apothicaires, 34298 Montpellier cedex 5 (France); Salem, N. [Institut Paoli-Calmettes, 232, boulevard Sainte-Marguerite, 13009 Marseille (France); Tessier, E. [Centre azureen de radiotherapie, 1, place du Docteur-Jean-Luc-Broquerie, 06250 Mougins (France); Ellis, S. [Centre catalan de radiotherapie, 80, rue Pascal-Marie-Agasse, 66000 Perpignan (France)

    2011-04-15

    Purpose. - Surgery is the treatment of choice for localized uterine sarcomas. We conducted a retrospective study to define prognostic factors. Patients and methods. - We studied 111 cases of patients treated by adjuvant radiotherapy for uterine sarcoma in seven French centers. The median decline was 31 months. We conducted a univariate analysis to identify factors correlated with local recurrence. The statistically significant factors were studied in multivariate analysis by Cox model. Results. - The median dose of external beam radiotherapy was 45 Gy. Forty-three percent of patients had vaginal vault brachytherapy and 21 % chemotherapy. Only 6.3 % of patients had complications of acute grade III and 8.1 % of long-term sequelae of radiotherapy. The survival rate at 5 years was 74.6 %. They noted 12.6 % of isolated locoregional recurrences, against 29.7 % for distant recurrences, 80 % were pulmonary. Factors correlated with the risk of locoregional relapse were menopausal status (P = 0.045) and surgical margins suspicious or not healthy (P = 0.0095). The chemotherapy did not improve overall survival or disease free survival but the numbers were low. Conclusion. - The postoperative radiotherapy provides good local control in this disease. Brachytherapy is sometimes done, but it does not improve local control. Chemotherapy is not a standard localized stage but the rate of metastatic recurrence calls for the development of strategies involving systemic treatment with radiotherapy. (authors)

  14. Prospective study on 12 patients of salivary glands radiotherapy as treatment of salivary stasis in patients suffering from amyotrophic lateral sclerosis; etude prospective sur 12 patients de radiotherapie des glandes salivaires comme traitement de la stase salivaire chez des patients atteints de sclerose laterale amyotrophique

    Energy Technology Data Exchange (ETDEWEB)

    Assouline, A.; Delanian, S. [Oncologie radiotherapie, centre clinique de la Porte-de-Saint-Cloud, Boulogne (France); Lenglet, T.; Bruneteau, G.; Le Forestier, N.; Salachas, F.; Lebouteux, M.; Abdelnour, M.; Meininger, V.; Pradat, P.F. [Departement des maladies du systeme nerveux, groupe hospitalier Pitie-Salpetriere, AP-HP, Paris (France)

    2011-10-15

    The authors report a study which aimed at assessing the efficiency and tolerance of salivary gland radiotherapy in patients suffering from amyotrophic lateral sclerosis. Twelve patients have been treated by conformational irradiation after a planning scanography with support mask. Results are discussed in terms of salivary discomfort (almost immediate disappearance in 11 cases), and other minor effects. Although a greater number of patients is still needed, the treatment gives promising results. Short communication

  15. The role of radiotherapy in the treatment of oral Kaposi's sarcoma. Place de la radiotherapie dans le traitement des sarcomes de Kaposi de la cavite buccale

    Energy Technology Data Exchange (ETDEWEB)

    Frikha, H; Le Bourgeois, J P; Haddad, E; Piedbois, P; Le Pechoux, C; Ghilezan, M; Mazeron, J J [Hopital Henri-Mondor, 94 - Creteil (France)

    1993-01-01

    The role of radiotherapy in the treatment of oral Kaposi's sarcoma needs to be defined. Over the past six years, 400 patients with AIDS-related epidemic Kaposi's sarcoma were referred to the oncology department of Henri Mondor Hospital; about 50% had oral Kaposi's lesions. Only 29 of the latter group had received oral cavity irradiation; palliation of pain was the most common indication. The age range was from 26-46 yr with a mean of 36 yr. Twenty-five patients were treated by megavolt age irradiation (4 MV X-rays) 22 of whom received 15 Gy (2 Gy/fraction, 8 Gy/week) and three 30 Gy (15 Gy followed by 3 weeks rest, then a further series of 15 Gy). Five patients were treated by orthovoltage irradiation (45 kV) and received 10-20 Gy (one patient received the two methods of irradiation). Treatment was generally successful in achieving palliation: of the 22 patients who received 15 Gy, 13.6% achieved complete remission and 86.4% partial remission with disappearance of pain; however, toxicity related to severe mucositis, even at relatively low doses and in spite of anti-mycotic treatment, is an argument for restrictive use of this modality.

  16. The role of radiotherapy in the treatment of a conventional Kaposi sarcoma; Place de la radiotherapie dans le traitement du sarcome de Kaposi classique

    Energy Technology Data Exchange (ETDEWEB)

    El Omrani, A.; Khouchani, M.; El Morjani, T.; Mharech, A.; Tahri, A. [CHU Mohammed-VI, Marrakech (Morocco)

    2011-10-15

    The authors report a study which aimed at establishing the epidemio-clinical and evolution profile of patients irradiated for a localized Kaposi sarcoma. This retrospective study is based on 10 patients treated between 2005 and 2009. All patients have been irradiated. Even though this pathology is a matter of discussion for its viral or genetic origin, its radio-sensitivity results in local control and a longer survival. Short communication

  17. Apport de la biopsie radioguidée dans le diagnostic histopathologique des tumeurs de l'enfant: expérience de l'Hôpital d'Enfant de Rabat

    Science.gov (United States)

    El Ochi, Mohamed Réda; Bellarbi, Salma; Rouas, Lamiae; Lamalmi, Najat; Malihy, Abderrahmane; Alhamany, Zaitouna; Cherradi, Nadia

    2015-01-01

    La biopsie radioguidée constitue une alternative à la biopsie chirurgicale invasive et à la cytologie pour le diagnostic des tumeurs pédiatriques. L'intérêt de notre étude est d’évaluer la valeur diagnostique des biopsies radioguidées examinées au laboratoire d'anatomopathologie de l'hôpital d'Enfants de Rabat (HER). L’étude a porté sur 78 biopsies radioguidées recueillies dans notre laboratoire entre janvier 2008 et décembre 2011. l’âge moyen des patients était de 5 ans et 10 mois avec une prédominance masculine (65,4%). La tumeur était abdominale dans 80% des cas, thoracique dans 15% cas, thoracique et abdominale dans 2,5% et sacrée dans 1,2%. Les biopsies étaient écho-guidées dans 90% des cas et scannoguidées dans 10% des cas. Le diagnostic histopathologique était posé dans 89% des cas. L'immuno-histochimie a été indiquée dans 35% des cas. Les diagnostics les plus fréquents étaient: tumeurs neuroblastiques (42 cas), lymphomes non hodgkiniens (10 cas), rhabdomyosarcomes (6 cas), autres (sarcome d'Ewing, néphroblastomes, tumeur myofibroblastique inflammatoire, maladies de Hodgkin, leucémie aiguë, hépatoblastome et ostéosarcome). Dans notre série, la biopsie radioguidée a permis un diagnostic histopathologique certain dans 89% des cas. Elle nécessite une étroite collaboration entre clinicien, radiologue et anatomopathologiste pour discuter son indication, afin de diminuer le nombre de biopsies peu ou non représentatives. PMID:26587165

  18. Interest of PET with F.D.G. in the follicular lymphomas; Interet de la TEP au FDG dans les lymphomes folliculaires

    Energy Technology Data Exchange (ETDEWEB)

    Albarghach, N.; Cornec, D.; Querellou, S.; Berthou, C.; Renaudineau, Y.; Pradier, O.; Cheze-Lerest, C. [CHU Morvan, 29 - Brest (France); Hatt, M.; Visvikis, D. [Inserm U650, 29 - Brest (France)

    2009-10-15

    For the follicular lymphomas, the PET is not in the systematic medical evaluation when it cannot be ignored in the evaluation of high grade non hodgkin lymphomas because it allows to make a complete extension evaluation and especially to help to define the target volume when the radiotherapy is indicated. The fixation of F.D.G. in follicular lymphomas was studied. We showed that the follicular lymphomas present in PET under the form of hypermetabolic injuries. It seems possible to consider the use of PET to help at the definition of target volumes when the radiotherapy is indicated. The intensity of fixation seems to have a predictive value for the therapy response in case of immunotherapy. The measurement of the active tumoral volume seems to have a predictive value for the response to the treatment that is worth being specified on a more important population. (N.C.)

  19. Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study.

    Science.gov (United States)

    Dupuis, Jehan; Emile, Jean-François; Mounier, Nicolas; Gisselbrecht, Christian; Martin-Garcia, Nadine; Petrella, Tony; Bouabdallah, Reda; Berger, Françoise; Delmer, Alain; Coiffier, Bertrand; Reyes, Félix; Gaulard, Philippe

    2006-12-15

    Peripheral T-cell lymphomas (PTCLs) are rare and have a dismal prognosis. The most frequent subtype is PTCL, unspecified. Epstein-Barr virus (EBV) has been detected in around 40% of cases, but its prognostic significance is not fully established. Lymph node samples from 110 patients with PTCL, unspecified included in LNH87 and LNH93 trials were available. EBV status was studied by EBV-encoded small RNA in situ hybridization (EBER-ISH). EBER-ISH showed positive cells in 45 (41%) of 110 patients. Pretreatment characteristics were comparable between positive and negative cases, except for male sex (80% versus 60%, respectively, P = .02). Only 50% of patients achieved complete remission with a 5-year event-free survival (EFS) and overall survival (OS) of 21% and 30%, respectively. EBER-ISH positivity was the sole factor linked with worse EFS, with a 5-year probability of 11% for positive patients. In univariate analysis, factors affecting OS were EBER-ISH positivity, high LDH level, and age older than 60 years. In multivariate analysis, EBER-ISH was associated with a worse OS in the elderly population. Time-dependent analysis showed that the negative impact of EBV was essentially seen in the first 2 years following diagnosis. These results warrant further studies regarding pathogenesis and specific treatment approaches for EBV-associated PTCL patients.

  20. Identifizierung Apoptose-induzierender Alkaloide der Pflanze Chelidonium Majus und des Präparates Ukrain in einem Lymphom-Modell

    OpenAIRE

    Habermehl, Daniel Frédéric

    2009-01-01

    Für das Krebsmedikament Ukrain, von Herstellerseite als semisynthetisches Derivat aus dem Schöllkraut-Alkaloid Chelidonin und dem Alkylanz Thiotepa beschrieben, wurde eine selektive zytotoxische Wirkung auf humane Tumor-Zelllinien in vitro beschrieben. Auch einige klinische Studien berichten über eine positive Wirkung des Präparates in der onkologischen Therapie. Allerdings werden Wirksamkeit und Zusammensetzung des Präparates kontrovers diskutiert. Ziel der vorliegenden Arbeit war die An...

  1. F.D.G.-PET scanning in managing patients with lymphoma; La place de la TEP au FDG dans l'evaluation des lymphomes

    Energy Technology Data Exchange (ETDEWEB)

    Bodet-Milin, C.; Kraeber-Bodere, F. [CHU de Nantes, Service de Medecine Nucleaire, Hotel-Dieu, 44 - Nantes (France); Salaun, P.Y. [CHU de Brest, Service de Medecine Nucleaire, 29 - Brest (France); Crespin, C.; Vuillez, J.P. [CHU de Grenoble, Service de Medecine Nucleaire, 38 - Grenoble (France); Kraeber-Bodere, F. [Centre Rene-Gauducheau, Service de Medecine Nucleaire, 44 - Saint-Herblain (France); CRCNA, Inserm UMR 892, 44 - Nantes (France)

    2009-08-15

    The place of positron emission tomography (PET) in the evaluation of diffuse at big cells B lymphomas and hodgkin lymphomas is validated. The clinical impact of the PET registered in end of therapy development is indisputable. recommendations must be followed for images interpretation. The PET is strongly recommended during the first evaluation of the disease because it is a reference examination that makes easy the interpretation at the end of the therapy and allows to evaluate the extension of the disease with a sensitivity and a specificity superior to the computerized tomography. the prognosis value of intermediate evaluations appears certain in the diffuse at big cells B lymphomas and the hodgkin lymphomas but the impact of an early therapy change induced by PET is still to determine. The criteria of interpretation of early evaluations are to standardize. for the other types of lymphomas, the PET can have an interest to confirm the the localized stages, especially for the follicular lymphomas and direct the biopsy for a patient ill of a low range lymphoma suspect of aggressive change. (N.C.)

  2. Influence d'une période de restriction alimentaire sur les marqueurs salivaires du stress, les paramètres psychologiques et la performance chez des haltérophiles de haut niveau

    OpenAIRE

    Durguerian , Alexandre

    2017-01-01

    Restricting dietary intake is a widespread method for losing weight in weight categories sports. Reduction of calorie intake results in an activation of the physiological stress systems, both at central and peripheral levels, aiming at preserving energy homeostasis. Nevertheless, the influence on physiological, psychological and physical parameters remains controversial and do not allows to clearly defining a negative impact of dietary restriction on health and performance level. The objectiv...

  3. Prospective assessment of the salivary function by parotid scintigraphy after radiotherapy of 27 nasopharyngeal cancers; evaluation prospective de la fonction salivaire par scintigraphie parotidienne apres radiotherapie de 27 cancers du nasopharynx

    Energy Technology Data Exchange (ETDEWEB)

    Mnejja, W.; Ghorbal, L.; Daoud, J. [Service de radiotherapie oncologique, CHU Habib-Bourguiba, Sfax (Tunisia); Kallel, F.; Guermazi, F. [Service de medecine nucleaire, CHU Habib-Bourguiba, Sfax (Tunisia); Frikha, M. [Service de carcinologie medicale, CHU Habib-Bourguiba, Sfax (Tunisia)

    2011-10-15

    As xerostomia is the main complication after radiotherapy of nasopharyngeal carcinomas, and affects life quality, this study aims at objectively assess the salivary function after radiotherapy of a nasopharyngeal cancer by parotid scintigraphy. 27 seven patients have been treated by radiotherapy with or without chemotherapy. Results are analyzed in terms of salivary toxicity, change of secretion function. No correlation was found between the xerostomia severity and scintigraphy results. Short communication

  4. L’exposition contrôlée à la lumière et à l’obscurité ajuste le rythme du cortisol salivaire chez les travailleurs de nuit

    Directory of Open Access Journals (Sweden)

    Anny Casademont

    2005-05-01

    Full Text Available Dans cette étude réalisée sur le terrain et en laboratoire, nous avons testé l’efficacité d’une intervention consistant à contrôler l’exposition à la lumière/obscurité de façon à favoriser l’adaptation circadienne au travail de nuit. Six travailleurs permanents de nuit (moyenne d’âge 37,1 ± σ : 8,1 ans avaient comme consigne de s’exposer de façon intermittente à une lumière blanche vive plein spectre (~2 000 lux au cours des 6 premières heures de leur quart de travail de 8 heures. Il leur était demandé de se protéger de la lumière solaire du matin avec des verres teintés (densité gris neutre, transmission visuelle de la lumière 15 % et de maintenir des épisodes réguliers de sommeil/obscurité dans une pièce très sombre. Ces épisodes devaient commencer 2 heures après la fin de chaque quart de travail de nuit. Cinq travailleurs du groupe contrôle (41,1 ± σ : 9,9 ans ont été étudiés alors qu’ils devaient uniquement maintenir un horaire régulier de sommeil/obscurité. Des procédures de routine constante, réalisées avant et après une série d’environ 12 quarts de travail de nuit s’échelonnant sur 3 semaines, ont montré chez les travailleurs du groupe traitement une variation significative dans l’heure d’apparition du pic de cortisol ainsi qu’un ajustement de ce rythme à un horaire de travail de nuit. Un plus petit changement de phase a été observé dans le groupe contrôle, ce qui suggère une adaptation partielle à l’horaire de travail de nuit. Nos résultats démontrent l’efficacité d’une exposition judicieuse à la lumière et à l’obscurité pour favoriser l’adaptation des rythmes physiologiques au travail de nuit.The efficacy of a light/darkness intervention designed to promote circadian adaptation to night shift work was tested in this combined field and laboratory study. Six permanent night shift workers (mean age: 37.1 / s: 8.1 years were instructed to expose themselves intermittently to full-spectrum bright white light (~2,000 lux in the first 6 hours of their 8-hour shift. They were asked to shield themselves from morning sunlight with tinted lenses (neutral grey density, 15% visual light transmission, and to maintain regular sleep/darkness episodes in darkened quarters beginning 2 hours after the end of each night shift. Five control group workers (41.1 / s: 9.9 years were observed in the presence of a regular sleep/darkness schedule only. Constant routines performed before and after a sequence of ~12 night shifts over 3 weeks revealed that treatment group workers displayed significant shifts in the time of peak cortisol expression and a realignment of the rhythm with the night-oriented schedule. Smaller phase shifts suggesting an incomplete adaptation to the shift work schedule were observed in the control group. Our observations support a careful control of the pattern of light and darkness exposure for the adaptation of physiological rhythms to night shift work.

  5. The place of radiotherapy in muco-epidermoid carcinomas of salivary glands in child; Place de la radiotherapie dans les carcinomes mucoepidermoides des glandes salivaires de l'enfant

    Energy Technology Data Exchange (ETDEWEB)

    Thariat, J. [Centre Antoine-Lacassagne, Nice (France); Temam, S. [Institut Gustave-Roussy, Villejuif (France); Orbach, D. [Institut Curie, Paris (France); Nicollas, R.; Penicaud, M. [Hopital La Timone, Marseille (France); Toussaint, B. [CHU, Nancy (France); Makeieff, M. [CHU, Montpellier (France); Laprie, A. [Institut Claudius-Regaud, Toulouse (France); Castillo, L. [CHU, Nice (France); Vedrin, P. [CHC de Cannes, Cannes (France)

    2011-10-15

    As muco-epidermoid carcinomas are the most frequent tumours of salivary glands for child, the authors report the study of the role of radiotherapy. This study is based on a survey performed in 34 paediatric departments. The authors analyse the age and gender, the use of irradiation, the tumour location, the tumour grade and size, the use of surgery and of radiotherapy, and survival. Radiotherapy is beneficial for high grade tumours, but cannot be recommended for low and intermediate grades. Short communication

  6. Cancer du sein au Cameroun, profil histo-épidémiologique: à propos de 3044 cas

    Science.gov (United States)

    Engbang, Jean Paul Ndamba; Essome, Henri; Koh, Valère Mve; Simo, Godefroy; Essam, Jean Daniel Sime; Mouelle, Albert Sone; Essame, Jean Louis Oyono

    2015-01-01

    Décrire les caractéristiques épidémiologiques et histo-pathologiques des tumeurs malignes du sein au Cameroun. Il s'agissait d'une étude rétrospective descriptive portant sur les tumeurs malignes du sein, colligées, dans les registres des différents laboratoires d'Anatomie Pathologique publiques et privés repartis dans cinq régions (centre, littoral, Ouest, Nord-ouest, Sud-ouest), pendant une période de 10 ans (2004-2013). Les paramètres étudiés étaient la fréquence, l’âge, le sexe, la localisation, le type et le grade histologique, et les récepteurs hormonaux. Un total de 3044 cas de cancers du sein a été recensé, soit une fréquence annuelle de 304,4 cas en moyenne. Le sexe féminin était le plus représenté avec 2971 cas (97,60%) et les hommes avec 73 cas (2,40%), soit un sexe ratio (H/F) de 0,02. L’âge moyen des patients était de 46±15,87 ans, avec des extrêmes de 13 et 95 ans. Selon la localisation, le sein gauche était atteint dans 1244 cas (52%) et le sein droit dans 1115 cas (47%). Au plan histologique, on retrouvait essentiellement des carcinomes avec 96,50% des cas, des sarcomes 1,39%, des lymphomes 1,07% et la maladie de Paget du mamelon, 1,03%. Les tumeurs épithéliales étaient infiltrantes dans 2049 cas (84,46%), avec une prédominance du carcinome canalaire infiltrant (1870 cas) et non infiltrantes dans 377 cas (15,54%). Le grade histo-pronostic de SBR avait révélé une prédominance du grade II dans 66% des cas. Les cancers du sein restent une pathologie fréquente au Cameroun et atteignent principalement la population féminine en âge de procréer. Ils sont caractérisés par la prédominance du carcinome canalaire infiltrant. PMID:26523182

  7. Les tumeurs malignes primitives de l’intestin grèle: Aspects cliniques et thérapeutiques de 27 patients

    Directory of Open Access Journals (Sweden)

    Abahssain Halima

    2011-03-01

    Full Text Available Les tumeurs malignes de l'intestin grèle (TMPIG sont des tumeurs rares. Elles représentent 1 à 5% de toutes les tumeurs du tube digestif. Elles sont caractérisées par une hétérogénéité anatomopathologique et une symptomatologie pauvre et non spécifique entrainant ainsi un retard diagnostic, des difficultés Thérapeutiques et donc un mauvais pronostic. Nous rapportant les caractéristiques épidémiologiques, diagnostiques et thérapeutiques ainsi que la survie des patients atteints des TMIG au sein de l’institut national d’oncologie de Rabat. Il s’agit d’une analyse rétrospective des dossiers cliniques des 27 patients ayant le diagnostic de tumeurs malignes de l’intestin grèle admis dans notre institut entre 1998 et 2002. L’âge médian était de 46 ans (15-70 ans. Le délai médian de diagnostic était de 6 mois (0-96 mois. La douleur abdominale était le symptôme le plus fréquent (77.8%. L’étude anatomopathologique a montré 63% de lymphome non Hodgkinie, 14.8% d’adénocarcinome, 7.4% de tumeur stromale, 7.4% de carcinome neuroendocrine et 7.4% de sarcome intestinal. Vingt patients (76. 9% ont eu une résection chirurgicale et 14 patients (53. 8% ont eu une chimiothérapie en fonction du stade de la maladie et du type histologique. Après un recul médian de 11.6 mois, la survie globale après 12 mois était de 44.4% et la médiane de survie était de 11.6 mois. Les tumeurs malignes de l’intestin grèle sont rares. Leur diagnostic est tardif limitant ainsi la prise en charge thérapeutique curative. Les cliniciens doivent ètre avertis des symptômes gastro-intestinaux non spécifiques

  8. Radiation therapy of epidemic kaposi sarcoma: the Henri-Mondor hospital experience (643 patients); Radiotherapie du sarcome de kaposi epidemique: l`experience de l`hopital Henri-Mondor (643 patients)

    Energy Technology Data Exchange (ETDEWEB)

    Belembaogo, E; Kirova, Y; Frikha, H; Yu, S; Piedbois, P; Le Bourgeois, J P [Hopital Henri-Mondor, 94 - Creteil (France). Dept. de cancerologie

    1998-01-01

    From June 1986 to December 1996, 643 patients presenting with acquired immunodeficiency syndrome (AIDS)-related epidemic Kaposi`s sarcoma were treated with irradiation at the Oncology Department of Henri Mondor University Hospital. Three-hundred eighty-seven patients (60 %) had previously received a treatment with interferon (259 patients, 40.2 %), vinblastine (225 patients, 34.5 %), doxorubicin (22 patients, 3.4 %), bleomycin (19 patients, 2.9 %), and/or antiviral treatment (216, 33.5 %). The radiotherapy was delivered by 4 MeV OR 8 MeV electron beam for extended cutaneous fields and 45-100 kV x-ray for localized fields. The delivered dose was 20 Gy in 2 weeks (2.5 Gy/fraction, 4 fractions/week) followed by 2 weeks rest and second series of 10 Gy in 1 week. For oral cavity lesions, we used a series of 15.2 Gy was delivered (1.9 Gy/fraction, 4 fractions/week), followed for three patients by a 3 week rest and by a similar second series of 15.2 Gy.Six-hundred and twenty-one patients were evaluable and the objective response rate was 92 %, with e complete regression of clinical and functional symptoms for all patients. The skin tolerance was good, with 7.3 % grade I reactions, 69.3 % of grade II reactions, and 23.4 % grade III reactions. There was a correlation between recurrence rate and the occurrence of opportunistic infections. This analysis shows the efficacy of dose radiotherapy for treatment of epidemic Kaposi sarcoma. (author)

  9. Ewing sarcoma localized on spine: a dose escalation study in child; Sarcome d'Ewing localise au rachis: une etude d'escalade de dose chez l'enfant

    Energy Technology Data Exchange (ETDEWEB)

    Vogin, G.; Marchesi, V. [Centre Alexis-Vautrin, Nancy (France); Biston, M.C.; Gassa, F. [Centre Leon-Berard, Lyon (France); Amessis, M.; Zefkili, S.; Helfre, S. [Institut Curie, Paris (France); De Marzi, L.; Lacroix, F.; Leroy, A. [Institut Curie, Orsay (France)

    2011-10-15

    The authors report the study of dose escalation for the treatment of spinal in two types of Ewing tumours. They used 5 dose levels at the rate of five 1,6 Gy per week. They compare different radiotherapy techniques: three-dimensional conformation radiotherapy, static intensity-modulated conformational radiotherapy, helical tomo-therapy, volume-modulated arc-therapy (VMAT), stereotactic radiotherapy, and proton-therapy (in passive diffusion). It appears that it is possible to safely and efficiently deliver until 70,4 Gy in some Ewing tumours. In child, exclusive radiotherapy might become a local treatment option and would require a clinic trial and comparison with exclusive surgery or post-operative radiotherapy. Short communication

  10. The role of radiotherapy in the treatment of oral Kaposi's sarcoma. Place de la radiotherapie dans le traitement des sarcomes de Kaposi de la cavite buccale

    Energy Technology Data Exchange (ETDEWEB)

    Frikha, H.; Le Bourgeois, J.P.; Haddad, E.; Piedbois, P.; Le Pechoux, C.; Ghilezan, M.; Mazeron, J.J. (Hopital Henri-Mondor, 94 - Creteil (France))

    1993-01-01

    The role of radiotherapy in the treatment of oral Kaposi's sarcoma needs to be defined. Over the past six years, 400 patients with AIDS-related epidemic Kaposi's sarcoma were referred to the oncology department of Henri Mondor Hospital; about 50% had oral Kaposi's lesions. Only 29 of the latter group had received oral cavity irradiation; palliation of pain was the most common indication. The age range was from 26-46 yr with a mean of 36 yr. Twenty-five patients were treated by megavolt age irradiation (4 MV X-rays) 22 of whom received 15 Gy (2 Gy/fraction, 8 Gy/week) and three 30 Gy (15 Gy followed by 3 weeks rest, then a further series of 15 Gy). Five patients were treated by orthovoltage irradiation (45 kV) and received 10-20 Gy (one patient received the two methods of irradiation). Treatment was generally successful in achieving palliation: of the 22 patients who received 15 Gy, 13.6% achieved complete remission and 86.4% partial remission with disappearance of pain; however, toxicity related to severe mucositis, even at relatively low doses and in spite of anti-mycotic treatment, is an argument for restrictive use of this modality.

  11. Interactions entre muqueuse orale, salive et molécules de la flaveur

    OpenAIRE

    Ployon, Sarah

    2016-01-01

    Le rôle de la salive dans la perception sensorielle est de plus en plus reconnu, notamment par le biais des interactions physico-chimiques pouvant s’établir entre protéines salivaires et constituants alimentaires. Ce travail s’intéresse à la pellicule salivaire, la couche de protéines salivaires ancrées aux cellules épithéliales, et vise à caractériser les interactions pouvant s’établir d’une part entre ces protéines et épithélium oral, et d‘autre part entre ces protéines et les molécules de ...

  12. High fetal irradiation: about one pregnant woman receiving infra diaphragmatic radiotherapy for Hodgkin lymphoma; Irradiation foetale elevee: a propos d'une femme dont la grossesse etait meconnue irradiee en sous-diaphragmatique pour un lymphome hodgkinien

    Energy Technology Data Exchange (ETDEWEB)

    Moreau, M.V.; Brunaud, C.; Marchesi, V.; Hoffstetter, S.; Peiffert, D. [Centre Alexis-Vautrin, Service de Radiotherapie, 54 - Vandoeuvre-les-Nancy (France); Bologna, S. [Centre Hospitalier Universitaire Nancy-Brabois, Service d' Hematologie, 54 - Vandoeuvre-les-Nancy (France)

    2007-12-15

    We report the case of a 19-year-old young woman for whom was discovered a pregnancy at the end of the irradiation for a Hodgkin lymphoma (stage IV bone Bb), initially treated by chemotherapy. The radiotherapy delivered 36 Gy in infra-diaphragmatic volumes (lumbo-aortic, spleen, L5), beginning in a pregnant patient for less than 4 amenorrhea weeks. The calculated received fetal dose (literature data, measurement with software T.P.S., measurement on phantom) is high: it's between 2.8 and 5 Gy. With a current follow-up of 4 years since the radiotherapy's end, the patient is in complete remission and her child presents with a normal development for the age, in spite of the infra diaphragmatic irradiation. (authors)

  13. Under - diaphragm irradiation of an osseous stage 4 Hodgkin lymphoma at a patient whose pregnancy was unknown; Irradiation sous-diaphragmatique d'un lymphome hodgkinien de stade 4 osseux chez une patiente dont la grossesse etait meconnue

    Energy Technology Data Exchange (ETDEWEB)

    Moreau, M.V.; Tournier-Rangeard, L.; Brunaud, C.; Marchesi, V.; Peiffert, D. [Centre Alexis-Vautrin, Service de Radiotherapie, 54 - Vandoeuvre-les-Nancy (France); Bologna, S. [Centre Hospitalier Universitaire Brabois, Service d' Hematologie, 54 - Vandoeuvre-les-Nancy (France)

    2007-11-15

    Four years after the irradiation, the patient was in situation of complete forgiveness: the child was normal, there was neither a deformation nor a mental disorder, but the neoplastic risk persists, thus long-term surveillance is imperative. If the pregnancy is known, we have to arrest the foetal risks incurred in order to propose a termination of pregnancy; therefore, are made the measures on phantoms of the dose that he would receive, according to the tumoral localization, to the dose necessary to eradicate the tumor, to the field and the possible masks for an optimal tumoral control. (N.C.)

  14. Assessment of low-dose radiotherapy (two 2 Gy sessions) for the cure of MALT lymphoma of the lung; evaluation de la radiotherapie faible (deux seances de 2 Gy) a visee curative dans le lymphome du Malt pulmonaire

    Energy Technology Data Exchange (ETDEWEB)

    Paumier, A.; Ghalibafian, M.; Gilmore, J.; Girinsky, T. [Departement de radiotherapie, institut de cancerologie Gustave-Roussy, Villejuif (France); Hanna, C.; Raphael, J.; Ferme, C.; Ribrag, V. [Departement d' hematologie, institut de cancerologie Gustave-Roussy, Villejuif (France)

    2011-10-15

    The authors report the assessment of low-dose radiotherapy (two sessions of 2 Gy in two days) for the curative treatment of mucosa-associated lymphoid tissue (MALT) lymphoma of the lung. The treatment of this lymphoma is discussed in terms of surgery, chemotherapy, radiotherapy, or even simple monitoring. The authors analyse the results obtained on nine patients who have been treated this way since 2002, straight away for some of them, after surgery or chemotherapy for others. Survival rate, recurrence, evolutions and responses are discussed. Short communication

  15. Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma : A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Etude des Lymphomes de l'Adulte Cohort Study

    NARCIS (Netherlands)

    van der Kaaij, Marleen A. E.; Heutte, Natacha; Meijnders, Paul; Abeilard-Lemoisson, Edwige; Spina, Michele; Moser, Elizabeth C.; Allgeier, Anouk; Meulemans, Bart; Simons, Arnold H. M.; Lugtenburg, Pieternella J.; Aleman, Berthe M. P.; Noordijk, Evert M.; Ferme, Christophe; Thomas, Jose; Stamatoullas, Aspasia; Fruchart, Christophe; Brice, Pauline; Gaillard, Isabelle; Bologna, Serge; Ong, Francisca; Eghbali, Houchingue; Doorduijn, Jeanette K.; Morschhauser, Franck; Sebban, Catherine; Roesink, Judith M.; Bouteloup, Marie; Van Hoof, Achiel; Raemaekers, John M. M.; Henry-Amar, Michel; Kluin-Nelemans, Hanneke C.

    2012-01-01

    Purpose In this large cohort of Hodgkin's lymphoma survivors with long follow-up, we estimated the impact of treatment regimens on premature ovarian failure (POF) occurrence and motherhood, including safety of nonalkylating chemotherapy and dose-response relationships for alkylating chemotherapy and

  16. Studies on the optimization of leukemia and non-Hodgkin lymphoma therapies using opioids, chemotherapy and radioimmunotherapy; Studien zur Optimierung von Leukaemie- und non-Hodgkin-Lymphom-Therapien durch den Einsatz von Opioiden, Chemotherapeutika und Radioimmuntherapien

    Energy Technology Data Exchange (ETDEWEB)

    Roscher, Mareike

    2013-05-24

    Despite complex treatment schedules for cancer, the occurrence of resistances and relapses is a major concern in oncology. Hence, novel treatment options are needed. In this thesis, different approaches using radioimmunotherapy and the opioid D,L-methadone alone or in combination with doxorubicin were analyzed regarding their cytotoxic potential and the triggered signalling pathways in sensitive and resistant leukaemia and non-Hodgkin lymphoma (NHL). The radioimmunoconjugates [Bi-213]anti-CD33 and [Bi-213]anti-CD20 for treatment of acute myeloid leukaemia (AML) or NHL, respectively, were applied exemplary for the use of targeted alpha-therapies (TAT). Depending on the analyzed cell lines, the used activity concentrations and specific activities (MBq/μg antibody) apoptosis was induced abrogating radio- and chemo-cross-resistances specifically. The cell death was caspase-dependent activating the mitochondrial pathway and was executed by downregulation of the anti-apoptotic proteins XIAP and Bcl-xL. D,L-Methadone induces apoptosis in vitro and in vivo in opioid-receptor (OR) expressing cells depending on the OR density and the used concentrations. Resistances could be overcome and proliferation was inhibited. In combination with doxorubicin, a synergistic effect regarding cytotoxicity in ex vivo patient cells and cell lines was observed. This effect depends on the increase of doxorubicin uptake co-administering D,L-methadone whereas doxorubicin enhances OR expression. The activation of OR leads to the downregulation of cAMP playing a pivotal role in apoptosis induction. In vivo, the therapeutic potential of D,L-methadone alone or in combination with doxorubicin could be proven as mice transplanted with human T-ALL-cells could be identified as tumour free. In summary, these studies show that TAT using [Bi-213]anti-CD33 and [Bi-213]anti-CD20 as well as the opioid D,L-methadone harbour the potential to optimize conventional treatment modalities for leukaemia and NHL.

  17. Browse Title Index

    African Journals Online (AJOL)

    Vol 19, No 3 (2017), La reinsertion sociale des enfants en difficultes dans les centres etatiques du ... Vol 15, No 3 (2013), La science administrative, Abstract ... salivaires accessoires de siege jugale a propos d'un cas et revue de la litterature.

  18. The recovery of the salivary function in the course of time among patients damaged by a cancer of the O.R.L. sphere treated by conformal irradiation with intensity modulation; La recuperation de la fonction salivaire au cours du temps chez les patients atteints de cancer de la sphere ORL traite par irradiation conformationnelle avec modulation d'intensite

    Energy Technology Data Exchange (ETDEWEB)

    Gardner, M.; Valinta, D.; Banal, P.; Roch, P.; Bensaoula, O.; Labib, A. [Centre Rene-Huguenin, 92 - Saint-Cloud (France); Halimi, P.; Hans, S. [Hopital Europeen Georges-Pompidou, 75 - Paris (France)

    2006-11-15

    The conformal radiotherapy with intensity modulation (R.C.M.I.) has allowed for 8 patients a partial preservation of the salivary production. The salivary production was insufficient to allow a correct quality of life for patients because the decrease of salivary production had a limited clinical translation. (N.C.)

  19. Un cas d'angiosarcome de l'oreille externe | Issara | Pan African ...

    African Journals Online (AJOL)

    L'angiosarcome de l'oreille est une tumeur maligne très rare, et localement très agressive. Elle représente 4-5% des sarcomes cutanés et moins de 1% de tous les sarcomes. Notre objectif est de décrire et de discuter les modalités diagnostiques et thérapeutiques de cette tumeur maligne. A travers le cas clinique d'une ...

  20. Simplified dose calculation method for mantle technique

    International Nuclear Information System (INIS)

    Scaff, L.A.M.

    1984-01-01

    A simplified dose calculation method for mantle technique is described. In the routine treatment of lymphom as using this technique, the daily doses at the midpoints at five anatomical regions are different because the thicknesses are not equal. (Author) [pt

  1. Conservative treatment of soft tissue sarcomas of the extremities. Functional evaluation with LENT-SOMA scales and the Enneking score; Traitement conservateur des sarcomes des tissus mous des membres. Evaluation du resultat fonctionnel selon l'echelle LENT-SOMA et le score de Enneking

    Energy Technology Data Exchange (ETDEWEB)

    Tawfiq, N.; Lagarde, P.; Thomas, L.; Kantor, G. [Institut Bergonie, Centre Regional de Lutte Contre le Cancer, Service de Radiotherapie, 33 - Bordeaux (France); Stockle, E. [Institut Bergonie, Centre Regional de Lutte Contre le Cancer, Service de Chirurgie, 33 - Bordeaux (France); Bui, B.N. [Institut Bergonie, Centre Regional de Lutte Contre le Cancer, Service d' Oncologie Medicale, 33 - Bordeaux (France)

    2000-12-01

    Objective. - The aim of this prospective study is the feasibility of late effects assessment by LENT-SOMA scales after conservative treatment of soft tissue sarcomas of the extremities and a comparison with the functional evaluation by the Enneking score. Patients and methods. - During the systematic follow-up consultations, a series of 32 consecutive patients was evaluated in terms of late effects by LENT SOMA scales and functional results by the Enneking score. The median time after treatment was 65 months. The treatment consisted of conservative surgery (all cases) followed by radiation therapy (29 cases), often combined with adjuvant therapy (12 concomitant radio-chemotherapy association cases out of 14). The assessment of the toxicity was retrospective for acute effects and prospective for the following late tissue damage: skin/subcutaneous tissues, muscles/soft tissues and peripheral nerves. Results. -According to the Enneking score, the global score for the overall series was high (24/30) despite four the scores zero for the psychological acceptance. According to LENT SOMA scales, a low rate of severe sequelae (grade 3-4) was observed. The occurrence of high-grade sequelae and their functional consequences were not correlated with quality of exeresis, dose of radiotherapy or use of concomitant chemotherapy. A complementarity was observed between certain factors of the Enneking score and some criteria of the LENTSOMA scales, especially of muscles/soft tissues. Conclusion. -The good quality of functional results was confirmed by the two mean scoring systems for late normal tissue damage. The routine use of LENT-SOMA seems to be more time consuming than the Enneking score (mean time of scoring: 1 3 versus five minutes). The LENT-SOMA scales are aimed at a detailed description of late toxicity and sequelae while the Enneking score provides a more global evaluation, including the psychological acceptance of treatment. The late effects assessment by the LENT-SOMA scales should be carried on in prospectives studies, especially in case of concomitant radio-chemotherapy. (author)

  2. The PET/T.D.M. with F.D.G. -({sup 18}F) appears more noticeable than the osseous scintigraphy in the Ewing sarcoma with osteo-medullar localizations; La TEP/TDM au FDG-(18F) apparait plus sensible que la scintigraphie osseuse dans le sarcome d'Ewing a localisations osteomedullaires

    Energy Technology Data Exchange (ETDEWEB)

    Girma, A.; Razzouk, M.; Carrier, P.; Darcourt, J. [Unite de medecine nucleaire, CHU l' Archet, Nice, (France); Paycha, F. [unite de medecine nucleaire, CHU Louis-Mourier, Colombes, (France); Deville, A. [unite de pediatrie, CHU l' Archet, Nice, (France); Boyer, C. [unite de radiologie, CHU l' Archet, Nice, (France); Piche, M. [unite d' anatomopathologie, CHU l' Archet, Nice, (France)

    2009-05-15

    The clinical case reported here illustrates the superiority of the PET/T.D.M. with F.D.G.({sup 18}F) on the osseous scintigraphy in the Ewing sarcoma. This difference comes from probably a major inter trabecular medullary injury that arouses only a limited cortical osteoblastic reaction, what explains its appellation of pass-wall tumor by the anatomical pathologists. (N.C.)

  3. Experience of the Casablanca radiotherapy-oncology centre on radiotherapy in the treatment of the adult Hodgkin lymphoma; Experience du centre de radiotherapie-oncologie de Casablanca sur la radiotherapie dans le traitement du lymphome de Hodgkin de l'adulte

    Energy Technology Data Exchange (ETDEWEB)

    Bouchbika, Z.; Benchakroun, N.; Sellai, N.; Jouhadi, H.; Tawfiq, N.; Sahraoui, S.; Benider, A. [Service radiotherapie-oncologie, CHU Ibn-Rochd, Casablanca (Morocco)

    2011-10-15

    The authors report the assessment of the local control, global survival and survival without recurrence, and also late complications, based on retrospective study over 8 years of 169 cases Hodgkin lymphoma in patients older than 18 (average age of 34) and who had been submitted to radiotherapy. Survival has been computed according to the Kaplan-Meier method. The authors notice that the recurrence rate is slightly higher than in the literature. During the considered period, radiotherapy was two-dimensional with higher doses than those corresponding to current standards. The improvement of radiotherapy techniques and the decrease of doses within the standards should improve the therapeutic results. Short communication

  4. Case report

    African Journals Online (AJOL)

    cqq1a

    5 sept. 2010 ... Abstract. Les tumeurs neuro-ectodermiques primitives ou sarcome d'Ewing sont classiquement des néoplasmes se développant aux dépends des tissus mous et des os. Les tumeurs neuro-ectodermiques primitives gastriques (pPNETs) sont extrêmement rares. Nous nous proposons, à travers le cas d'un.

  5. Journal Tunisien d'ORL et de Chirurgie Cervico-Faciale - Vol 26 ...

    African Journals Online (AJOL)

    Sarcome d'ewing- Une localisation exceptionnelle : Le rocher · EMAIL FREE FULL TEXT EMAIL FREE FULL TEXT DOWNLOAD FULL TEXT DOWNLOAD FULL TEXT. K Khamassi, N Jlassi, SB Ghamra, H Jaafoura, R Lahiani, D Nejah, MB Salah, N Kaffel, M Ferjaoui, 49-52 ...

  6. Images in medicine

    African Journals Online (AJOL)

    abp

    11 mars 2016 ... &Corresponding author: Youssef Omor, Service d'Imagerie Médicale, Radiologie Centrale, CHU Avicenne, Rabat, Maroc. Key words: Sarcome d´Ewing, parties molles, région cervicale. Key words: Ewing's sarcoma, soft parts, cervical region. Received: 02/11/2015 - Accepted: 03/01/2016 - Published: ...

  7. Author Details

    African Journals Online (AJOL)

    Ouraini, Saloua. Vol 22, No 1 (2015) - Articles Lymphome malin non hodgkinien du cavum: protocoles thérapeutiques et facteurs pronostiques. Abstract PDF · Vol 22, No 1 (2015) - Articles Acouphènes révélateurs de la maladie de Horton Abstract PDF. ISSN: 1937-8688.

  8. Author Details

    African Journals Online (AJOL)

    Carcinome spinocellulaire de la levre inferieure: Sur cicatrice de lupus erythemateux chronique. Abstract PDF · Vol 24 (2010) - Articles Lymphomes malins non-hodgkiniens primitifs des amygdales palatines. Abstract PDF · Vol 28 (2012) - Articles L'acupuncture : comme alternative dans la prise en charge de la paralysie ...

  9. Structural and functional assessment of the interaction between focal adhesion kinase and sarcomeric myosin

    OpenAIRE

    Aline Mara dos Santos

    2011-01-01

    Resumo: A tirosino-quinase de adesão focal (FAK) tem papel crítico na mediação da migração, sobrevivência e proliferação celular. Estudos anteriores de nosso laboratório demonstraram que a FAK é ativada pelo estresse mecânico em miócitos cardíacos e que ela se coimunoprecipita com a miosina sarcomérica. No presente trabalho foi demonstrado que o domínio FERM da FAK medeia à interação com a miosina sarcomérica, sendo que esta interação leva a inibição da autofosforilação da FAK, enquanto que a...

  10. Une tumeur neuroectodermique primitive périphérique à localisation ...

    African Journals Online (AJOL)

    Les tumeurs neuro-ectodermiques primitives ou sarcome d'Ewing sont classiquement des néoplasmes se développant aux dépends des tissus mous et des os. Les tumeurs neuro-ectodermiques primitives gastriques (pPNETs) sont extrêmement rares. Nous nous proposons, à travers le cas d'un patient, opéré pour une ...

  11. Case report

    African Journals Online (AJOL)

    abp

    27 août 2015 ... familiaux, a été admis le 03 Mars 2012 aux urgences chirurgicales du Centre Hospitalier Universitaire Aristide le Dantec de Dakar, pour des douleurs .... mélanome, le sarcome d'Ewing, l'angiosarcome, le séminome, le carcinome adénoïde kystique et le carcinome bronchique. Il s'agit du marqueur ...

  12. MAQUETTE ORL Décembre 2004

    African Journals Online (AJOL)

    et associé à une érosion du mur de la logette et de lʼos temporal ( Fig1). Lʼimagérie en résonnance magnétique (IRM) confirme la lésion tissulaire du conduit auditif externe gauche éten- due à lʼ lʼoreille moyenne avec envahissement de la paro-. J. TUN ORL - N° 24 JUIN 2010. 87. SARCOME DʼEWING DU ROCHER.

  13. Case report

    African Journals Online (AJOL)

    abp

    3 juin 2015 ... La localisation mammaire est très rare, certains auteurs la considère comme un sous-groupe des sarcomes des tissus mous et ne font pas de différence entre une fibromatose agressive et un fibrosarcome de bas grade. Patient et observation. Patiente âgée de 30 ans, célibataire, ayant comme ATCD une.

  14. Mise au point

    African Journals Online (AJOL)

    région épigastrique de taille 15-10 cm, non douloureuse à la palpation, ferme, de contour régulier et à surface lisse. Devant ce tableau, nous avons réalisé : J. TUN ORL - N° 20 JUIN 2008. 62. LYMPHOME DE BURKITT PÉDIATRIQUE. À RÉVÉLATION ORL : QUELLE PRISE EN CHARGE EN MILIEU SUB SAHÉLIEN ?

  15. Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1

    OpenAIRE

    Guan, Jian; Gluckman, Peter; Yang, Panzao; Krissansen, Geoff; Sun, Xueying; Zhou, Yongzhi; Wen, Jingyuan; Phillips, Gemma; Shorten, Paul R.; McMahon, Chris D.; Wake, Graeme C.; Chan, Wendy H. K.; Thomas, Mark F.; Ren, April; Moon, Steve

    2014-01-01

    The homeostasis of insulin-like growth factor-1 (IGF-1) is essential for metabolism, development and survival. Insufficient IGF-1 is associated with poor recovery from wounds whereas excessive IGF-1 contributes to growth of tumours. We have shown that cyclic glycine-proline (cGP), a metabolite of IGF-1, can normalise IGF-1 function by showing its efficacy in improving the recovery from ischemic brain injury in rats and inhibiting the growth of lymphomic tumours in mice. Further investigation ...

  16. No activation of new initiation points for deoxyribonucleic acid replication in BALB/c 3T3 cells transformed by Kirsten sarcoma virus

    International Nuclear Information System (INIS)

    Oppenheim, A.; Horowitz, A.T.

    1981-01-01

    BALB/c 3T3 cells were transformed by Kirsten sarcoma virus, and five clones were isolated in soft agar. Average replicon sizes of the transformed cell lines were stimated by the method of fiber-autoradiography and found to be the same size as the nontransformed 3T3 cells, analyzed in parallel. The results indicate that, unlike simian virus 40 and Epstein-Barr virus, Kirsten sarcoma virus does not activate new initiation points for cellular deoxyribonucleic acid replication in murine sarcome virus-transformed BALB/c 3T3 cells

  17. Radiation therapy of Kaposi's sarcoma in AIDS: Memorial Sloan-Kettering experience

    International Nuclear Information System (INIS)

    Nisce, L.Z.; Safai, B.

    1985-01-01

    In 1980 the authors reported their experience in the management of Kaposi's sarcoma (KS) affecting elderly men of Jewish or Italian descent. Since the outbreak of KS in 1981 among young male homosexuals with acquired immune deficiency syndrome (AIDS) the KS in the elderly has been subsequently called classical Kaposi's sarcome (CKS) in order to differentiate it from the KS in AIDS. The radiosensitivity of CKS is well documented. This report describes the authors' early experience in the radiation therapy of KS in AIDS compared with CKS and also discusses the problems related to the irradiation of the immunocompromised patient

  18. Estudio experimental de la expresión de las proteínas de la pared vesical en la obstrucción del tracto urinario inferior en el conejo

    OpenAIRE

    Salinas Casado, J.; Virseda Chamorro, M.; Martín Vega, A.; Henández Lao, A.; Herrero Payo, J.A.

    2004-01-01

    OBJETIVOS: Determinar la relación de los niveles tisulares de las proteínas contráctiles: actina total, beta-actina, alfa-actina sarcomérica y caldesmón y de la "Heat Stress Protein" HSP-70, con la obstrucción parcial del tracto urinario inferior. MATERIAL Y MÉTODOS: Se realizó un estudio experimental en 43 conejos machos neozelandeses que fueron divididos en un grupo control y seis grupos experimentales a los que se les realizó obstrucción parcial del tracto urinario inferior mediante ligadu...

  19. Primary EBV-positive Hodgkin's lymphoma of the CNS under azathioprine treatment. Case report and review of the literature

    Energy Technology Data Exchange (ETDEWEB)

    Henkenberens, Christoph; Christiansen, Hans [Medizinische Hochschule Hannover, Klinik fuer Strahlentherapie und Spezielle Onkologie, Hannover (Germany); Franzke, Anke [Medizinische Hochschule Hannover, Klinik fuer Haematologie, Haemostaseologie, Onkologie und Stammzelltransplantation, Hannover (Germany); Raab, Peter [Medizinische Hochschule Hannover, Institut fuer Diagnostische und Interventionelle Neuroradiologie, Hannover (Germany); Oschlies, Ilske; Klapper, Wolfram [Universitaetsklinikum Schleswig-Holstein, Institut fuer Pathologie, Sektion Haematopathologie, Kiel (Germany)

    2014-09-15

    Retrospective and prospective cohort studies suggest that central nervous system involvement occurs in approximately 0.5 % of patients with advanced Hodgkin's lymphoma. The isolated primary intracranial manifestation of Hodgkin's lymphoma is an extremely rare finding, with few cases reported in the literature. Little is known about the optimal treatment and prognosis of these tumors. Here, we present a case report with a review of the literature. A 47-year-old Caucasian man with persistent frontal headache and unspecific vertigo for half a month was diagnosed with nodular space-occupying lesions in the cerebellum. His medical history included multiple sclerosis, which was treated for 20 years with the immunosuppressive drug azathioprine. Further staging revealed no additional lesions suspected of being malignant. The patient underwent total tumor resection. Immunohistopathological examination showed Epstein-Barr virus-associated classic Hodgkin's lymphoma. Diagnostic bone marrow punction excluded lymphoma involvement of the bone marrow. The patient had no B symptoms. Consequently, the patient was classified as having stage I{sub E}A disease according to the Modified Ann Arbor Classification of Hodgkin Lymphoma and received systemic chemotherapy followed by radiation therapy for the former cerebellar tumor region. He was in complete clinical remission at the last follow-up 9 months after the initial diagnosis. This case report and literature review suggest that multimodal treatment leads to a remarkable clinical outcome in Hodgkin's lymphoma with intracranial involvement. (orig.) [German] Retrospektive und prospektive Kohortenstudien deuten daraufhin, dass eine Beteiligung des zentralen Nervensystems (ZNS) in etwa bei 0,5 % der Patienten mit fortgeschrittenem Hodgkin-Lymphom auftritt. Die isoliert primaer intrakranielle Manifestation des Hodgkin-Lymphoms ist extrem selten, mit wenigen bisher bekannten Faellen. Wenig ist auch ueber die optimale

  20. The Haiti research-based model of international public health collaboration: the GHESKIO Centers.

    Science.gov (United States)

    Pape, Jean W; Severe, Patrice D; Fitzgerald, Daniel W; Deschamps, Marie M; Joseph, Patrice; Riviere, Cynthia; Rouzier, Vanessa; Johnson, Warren D

    2014-01-01

    For 3 decades, GHESKIO (the Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes), the Haitian Ministry of Health, and Weill Cornell have pursued a tripartite mission of service, training, and translational research. The initial focus was on AIDS and tuberculosis. The mission has expanded to include the local community and now provides maternal-child health, family planning, cancer prevention and treatment, immunizations (including human papillomavirus, cholera), and primary education through vocational and microcredit programs. Outcome measures include a reduction in HIV prevalence from 6.2% to the current 2.2%, extensive tuberculosis and cholera prevention and treatment programs, and national training programs for biomedical and community health workers.

  1. Liposarcome dorsal: aspect clinique rare

    Science.gov (United States)

    Agbessi, Odry; Arrob, Adil; Fiqhi, Kamal; Khalfi, Lahcen; Nassih, Mohammed; El Khatib, Karim

    2015-01-01

    Décrit la première fois par Virchow en 1860, le liposarcome est une tumeur mésenchymateuse rare. Cette rareté est relative car les liposarcomes représentent quand même 14 à 18% de l'ensemble des tumeurs malignes des parties molles et ils constituent le plus fréquent des sarcomes des parties molles. Pour la majorité des auteurs, il ne se développerait jamais sur un lipome ou une lipomatose préexistant. Nous rapportons un cas de volumineux liposarcome de la face dorsale du tronc. L'histoire de la maladie, l'aspect clinique inhabituel « de tumeur dans tumeur », l'aspect de la pièce opératoire nous fait évoquer la possibilité de la transformation maligne d'un lipome bénin préexistant. PMID:26113914

  2. La tuberculose extra-ganglionnaire primitive de la sphère ORL: à propos de 15 cas

    Science.gov (United States)

    Touati, Mohamed Mliha; Darouassi, Youssef; Chihani, Mehdi; Lakouichmi, Mohammed; Tourabi, Khalid; Ammar, Haddou; Bouaity, Brahim

    2014-01-01

    Les localisations ORL extra ganglionnaires de la tuberculose sont rares. La symptomatologie clinique ainsi que les examens paracliniques sont souvent trompeurs,posant ainsi le problème de diagnostic différentiel avec la pathologie tumorale. Nous rapportons 15 cas de localisations extra ganglionnaires de tuberculose, colligés au service ORL et CCF de l'Hopital Militaire Avicenne de Marrakech colligés entre 2009 et 2013. L’âge moyen de nos patients est de 33 ans. L’étude topographique a montré 6 cas au niveau du cavum, un cas de miliaire tuberculeuse pharyngée, 4 cas laryngés; 2 localisations auriculaires; 1 parotidienne et 1 localisation sous maxillaire. Le diagnostic était anatomopathologiquedans tous les cas. Tous nos patients ont reçu un traitement antituberculeux avec une bonne évolution. Mots-clés: Tuberculose, amygdale, rhinopharynx, larynx, glandes salivaires,Oreille moyenne. PMID:25815100

  3. Imaging of nasopharyngeal diseases; Bildgebung bei Erkrankungen des Nasopharynx

    Energy Technology Data Exchange (ETDEWEB)

    Koesling, S.; Hofmockel, T. [Martin-Luther-Universitaet Halle-Wittenberg, Klinik und Poliklinik fuer Diagnostische Radiologie, Halle (Germany); Knipping, S. [Martin-Luther-Universitaet Halle-Wittenberg, Klinik und Poliklinik fuer Hals-, Nasen-, Ohrenheilkunde, Kopf- und Halschirurgie, Halle (Germany)

    2009-01-15

    This article gives an overview about the main nasopharyngeal pathologies and incidental findings, which a radiologist could be confronted with in daily practice. These include nasopharyngeal cysts, lymphoid hyperplasia, juvenile angiofibroma, carcinomas and non-Hodgkin lymphoma. Typical radiological findings, possibilities for making a specific diagnosis, differential diagnosis and description of the spread of a neoplasm are the central points. Investigation techniques and clinical signs are briefly summarized. (orig.) [German] Dieser Beitrag gibt einen Ueberblick ueber nasopharyngeale Erkrankungen und Zufallsbefunde, mit denen der Radiologe haeufig und weniger haeufig konfrontiert werden kann. Dazu zaehlen zystische Raumforderungen, die hyperplastische Rachenmandel, das juvenile Nasenrachenfibrom, Nasopharynxkarzinom und Non-Hodgkin-Lymphom. Im Vordergrund stehen dabei das radiologische Erscheinungsbild, Moeglichkeiten einer artdiagnostischen Zuordnung, differenzialdiagnostische Aspekte und bei Neoplasien Aussagen zur Ausbreitungsdiagnostik. Untersuchungstechnische und klinische Aspekte sowie die Diagnosesicherung werden kurz erwaehnt. (orig.)

  4. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells

    International Nuclear Information System (INIS)

    Kadivar, Mehdi; Khatami, Shohreh; Mortazavi, Yousef; Shokrgozar, Mohammad Ali; Taghikhani, Mohammad; Soleimani, Masoud

    2006-01-01

    Cardiomyocyte loss in the ischemically injured human heart often leads to irreversible defects in cardiac function. Recently, cellular cardiomyoplasty with mesenchymal stem cells, which are multipotent cells with the ability to differentiate into specialized cells under appropriate stimuli, has emerged as a new approach for repairing damaged myocardium. In the present study, the potential of human umbilical cord-derived mesenchymal stem cells to differentiate into cells with characteristics of cardiomyocyte was investigated. Mesenchymal stem cells were isolated from endothelial/subendothelial layers of the human umbilical cords using a method similar to that of human umbilical vein endothelial cell isolation. Isolated cells were characterized by transdifferentiation ability to adipocytes and osteoblasts, and also with flow cytometry analysis. After treatment with 5-azacytidine, the human umbilical cord-derived mesenchymal stem cells were morphologically transformed into cardiomyocyte-like cells and expressed cardiac differentiation markers. During the differentiation, cells were monitored by a phase contrast microscope and their morphological changes were demonstrated. Immunostaining of the differentiated cells for sarcomeric myosin (MF20), desmin, cardiac troponin I, and sarcomeric α-actinin was positive. RT-PCR analysis showed that these differentiated cells express cardiac-specific genes. Transmission electron microscopy revealed a cardiomyocyte-like ultrastructure and typical sarcomers. These observations confirm that human umbilical cord-derived mesenchymal stem cells can be chemically transformed into cardiomyocytes and can be considered as a source of cells for cellular cardiomyoplasty

  5. Intensive combined modality therapy of small round cell and undifferentiated sarcomas in children and young adults

    International Nuclear Information System (INIS)

    Bader, J.L.; Dewan, R.; Watkins, E.; Kinsella, T.J.; Glatstein, E.; STeinberg, S.M.

    1989-01-01

    Seventy-five patients (ages 4-35 years) with the following small round cell tumors and undifferentiated sarcoma were treated at the National Cancer Institute: Ewing's sarcome (n=32), peripheral neuroepithelioma (n=14), rhabdomyosarcoma (n=24), undifferentiated sarcoma (n=5). Most patients had poor prognostic features including 36 (48%) with metastatic disease, and 42 (56%) with central (truncal) tumors (22 in the pelvis). Treatment included 5 cycles of intensive induction chemotherapy with vincristine, cyclophosphamide and adriamycin, plus aggressive local radiation therapy using simulation and computerized treatment planning for all patients. Thereafter, complete clinical responses were consolidated with intensive chemotherapy, total body irradiation and autologous bone marrow transplantation. There were three local only failures, 10 local plus distant failures, 36 distant only failures, 3 treatment-related deaths, and one intercurrent death. Overall actuarial survival and event-free survival at 4 years are 49 and 29%, respectively. Actuarial freedom from local progression was seen in 74% of patients at 4 years, quite remarkable considering the bulk and location of most of these tumors. Without aggressive surgery, many of these high risk patients had satisfactory outcomes, but better systemic treatments are still needed.(author). 44 refs.; 8 figs.; 6 tabs

  6. Effectiveness of Oral Cholera Vaccine in Haiti: 37-Month Follow-Up.

    Science.gov (United States)

    Sévère, Karine; Rouzier, Vanessa; Anglade, Stravinsky Benedict; Bertil, Claudin; Joseph, Patrice; Deroncelay, Alexandra; Mabou, Marie Marcelle; Wright, Peter F; Guillaume, Florence Duperval; Pape, Jean William

    2016-05-04

    The first oral cholera vaccine (OCV) campaign, since its prequalification by the World Health Organization, in response to an ongoing cholera epidemic (reactive vaccination) was successfully conducted in a poor urban slum of approximately 70,000 inhabitants in Port-au-Prince, Haiti, in 2012. Vaccine coverage was 75% of the target population. This report documents the impact of OCV in reducing the number of culture-confirmed cases of cholera admitted to the Groupe Haïtien d'Etude du Sarcome de Kaposi et des Infections Opportunistes (GHESKIO) cholera treatment center from that community in the 37 months postvaccination (April 2012-April 30, 2015). Of 1,788 patients with culture-confirmed cholera, 1,770 (99%) were either from outside the vaccine area (1,400 cases) or from the vaccinated community who had not received OCV (370 cases). Of the 388 people from the catchment area who developed culture-confirmed cholera, 370 occurred among the 17,643 people who had not been vaccinated (2.1%) and the remaining 18 occurred among the 52,357 people (0.034%) who had been vaccinated (P cholera in outbreak settings. © The American Society of Tropical Medicine and Hygiene.

  7. Biodistribution and pharamacokinetics of /sup 195m/Pt-labeled cis-dichlorotrans-dihydroxo-bis(isopropylamine)platinum(IV), CHIP, in normal female Fischer 344 rat

    International Nuclear Information System (INIS)

    Hoeschele, J.D.; Ferren, L.A.; Roberts, J.A.; Whitfield, L.R.

    1983-01-01

    The discovery and successful clinical application of the potent anti-tumor compound, cis-Dichlorodiammineplatinum(II), cis-DDP* has stimulated considerable interest in developing effective but less toxic second-generation platinum antitumor drugs. One such candidate drug is cis-Dichloro-trans-dihydroxo-bis-(isopropylamine)platinum(IV), cis-trans-[PtCl 2 (OH) 2 (i-PrNH 2 ) 2 ], (CHIP). An important feature of this Pt(IV) agent is that in addition to exhibiting a generally milder clinical toxicity than cisplatin, the dose-limiting toxicity of CHIP is the more common myelosuppression rather than the less desirable nephrotoxicity. Also, CHIP has been reported recently to be more effective than cisplatin against both alkylating agent sensitive and resistant strains of the Yoshida sarcoms. A microscale synthesis for /sup 195m/Pt-labelled CHIP and the tissue distribution and pharmacokinetic properties of this agent in normal female Fischer 344 rats are reported. A comparison with similar data for /sup 195m/Pt-cis-DDP is included

  8. Checkpoint inhibitors and radiation treatment in Hodgkin's lymphoma. New study concepts of the German Hodgkin Study Group

    Energy Technology Data Exchange (ETDEWEB)

    Baues, C.; Semrau, R.; Marnitz, S. [University of Cologne, Medical Faculty, Department of Radiooncology, Cologne (Germany); University of Cologne, German Hodgkin Study Group (GHSG), Cologne (Germany); Gaipl, U.S. [University Hospital Erlangen, Department of Radiooncology, Erlangen (Germany); Broeckelmann, P.J.; Engert, A. [University of Cologne, German Hodgkin Study Group (GHSG), Cologne (Germany); University of Cologne, Medical Faculty, Department of Internal Medicine I, Cologne (Germany); Rosenbrock, J. [University of Cologne, Medical Faculty, Department of Radiooncology, Cologne (Germany)

    2017-02-15

    Patients with classical Hodgkin's lymphoma (cHL) have a good prognosis even in advanced stages. However, combined chemo- and radiotherapy, as the standard of care, is also associated with treatment-related toxicities such as organ damage, secondary neoplasias, infertility, or fatigue and long-term fatigue. Many patients suffer from this burden although their cHL was cured. Therefore, the efficacy of immune checkpoint inhibitors like anti-PD1/PD-L1 antibodies in the treatment of solid cancers and also in HL offers new options. A remarkable and durable response rate with a favorable toxicity profile was observed in heavily pretreated cHL patients. Planning to perform prospective randomized clinical trials in the content of radio-immune treatment in patients with Hodgkin's lymphoma (HL), we transferred the results of preliminary clinical studies and basic research in clinical relevant study concepts. Based on these promising early phase trial data, the German Hodgkin Study Group (GHSG) will investigate innovative treatment regimens in upcoming phase II trials. The therapeutic efficacy and potential synergies of anti-PD1 antibodies in combination with chemo- or radiotherapy will be investigated in various settings of HL. (orig.) [German] Patienten mit einem klassischen Hodgkin-Lymphom (cHL) haben ueber alle Stadien hinweg eine gute Prognose. Allerdings treten unter der kombinierten Therapie mit Chemotherapie und Bestrahlung therapieabhaengige Toxizitaeten wie z. B. Organschaeden, Sekundaertumoren, Fatigue oder Langzeit-Fatigue auf. Viele Patienten leiden trotz einer Heilung an diesen Symptomen. Daher bietet die nachgewiesene Wirksamkeit der Anti-PD1/PD-L1-Antikoerper bei soliden Tumoren, aber auch beim HL neue Behandlungsoptionen. Bei intensiv vorbehandelten Patienten mit rezidiviertem cHL wurde bei guter Vertraeglichkeit eine hohe Ansprechrate mit z. T. langanhaltenden Remissionen beobachtet. Im Rahmen der Planung prospektiver randomisierter Studien im

  9. Possibilities of whole-body MRI for investigating musculoskeletal diseases; Moeglichkeiten der Ganzkoerper-MRT zur Diagnostik muskuloskelettaler Erkrankungen

    Energy Technology Data Exchange (ETDEWEB)

    Lenk, S.; Claussen, C.D.; Schlemmer, H.P. [Klinikum der Eberhardt-Karls-Universitaet Tuebingen, Abteilung fuer Diagnostische Radiologie (Germany); Fischer, S. [Universitaetsklinikum Tuebingen, Abteilung fuer Strahlentherapie (Germany); Koetter, I. [Universitaetsklinikum Tuebingen, Abteilung fuer Haematoonkologie (Germany)

    2004-09-01

    This contribution outlines possibilities and limitations of whole-body MRI for investigating musculoskeletal diseases. Benefits and drawbacks of the novel whole-body MRI technology are discussed and a possible whole-body MRI sequence protocol for musculoskeletal examinations is proposed. Muscle, joint and bone diseases are discussed in which the application of whole-body MRI may be of advantage. Particularly, polymyositis, muscledystrophy, rheumatoid arthritis, spondylitis ancylosans, multiple trauma, skeletal metastases, multiple myeloma and malignant lymphoma are mentioned. Whole-body MRI opens new advantages for the examination of multifocal musculoskeletal diseases. The clinical benefit of this method for particular diseases has to be evaluated in further studies, however. (orig.) [German] Dieser Beitrag gibt eine Uebersicht ueber die Moeglichkeiten und Limitationen der Ganzkoerper-MRT fuer die Diagnostik von Erkrankungen des muskuloskelettalen Systems. Es werden die Vor- und Nachteile der Ganzkoerper-MRT eroertert und ein Sequenzprotokoll fuer die muskuloskelettale Diagnostik vorgeschlagen. Auf Muskel-, Gelenk- und Knochenerkrankungen, bei denen der Einsatz der Ganzkoerper-MRT indiziert erscheint, dabei insbesondere Polymyositis, Muskeldystrophie, rheumatoide Arthritis, Spondylitis ankylosans, Polytrauma, Skelettmetastasen, Plasmozytom und das maligne Lymphom wird eingegangen. Die Ganzkoerper-MRT bietet neue Moeglichkeiten, insbesondere zur Ausbreitungsdiagnostik und Verlaufskontrolle multifokaler muskuloskelettaler Erkrankungen. Der klinische Nutzen dieser Methode fuer die einzelnen Erkrankungsentitaeten muss in weiteren Studien evaluiert werden. (orig.)

  10. Diffuse large B cell lymphoma of thyroid as a masquerader of anaplastic carcinoma of thyroid, diagnosed by FNA: a case report.

    Science.gov (United States)

    Daneshbod, Yahya; Omidvari, Shapour; Daneshbod, Khosrow; Negahban, Shahrzad; Dehghani, Mehdi

    2006-10-19

    Both thyroid lymphoma and anaplastic carcinoma of thyroid present with rapidly growing mass in eldery patients. Anaplastic carcinoma has high mortality rate and combination of surgery, radiation therapy and multidrug chemotherapy are the best chance for cure. Prognosis of thyroid lymphoma is excellent and chemotherapy for widespred lymphoms and radiotherapy with or without adjuvant chemotherapy for tumors localized to the gland, are the treatment of choice. This article reports a 70 year old man presenting with diffuse neck swelling and hoarseness of few weeks duration. Fine needle aspiration was done and reported as anaplastic carcinoma of thyroid which thyroidectomy was planned. The slides were sent for second opinion. After review, with initial diagnosis of anaplastic carcinoma versus lymphoma, immunocytochemical study was performed. Smears were positive for B cell markers and negative for cytokeratin, so with the impression of diffuse large B cell lymphoma, the patient received two courses of chemotherapy by which the tumor disappeared during two weaks. Despite previous reports, stating easy diagnosis of high-grade thyroid lymphoma on the grounds of cytomorphological features we like to emphasize, overlapping cytologic features of the curable high grade thyroid lymphoma form noncurable anaplastic thyroid carcinoma and usefulness of immunocytochemistry to differentiate these two disease.

  11. Cyclic glycine-proline regulates IGF-1 homeostasis by altering the binding of IGFBP-3 to IGF-1

    Science.gov (United States)

    Guan, Jian; Gluckman, Peter; Yang, Panzao; Krissansen, Geoff; Sun, Xueying; Zhou, Yongzhi; Wen, Jingyuan; Phillips, Gemma; Shorten, Paul R.; McMahon, Chris D.; Wake, Graeme C.; Chan, Wendy H. K.; Thomas, Mark F.; Ren, April; Moon, Steve; Liu, Dong-Xu

    2014-03-01

    The homeostasis of insulin-like growth factor-1 (IGF-1) is essential for metabolism, development and survival. Insufficient IGF-1 is associated with poor recovery from wounds whereas excessive IGF-1 contributes to growth of tumours. We have shown that cyclic glycine-proline (cGP), a metabolite of IGF-1, can normalise IGF-1 function by showing its efficacy in improving the recovery from ischemic brain injury in rats and inhibiting the growth of lymphomic tumours in mice. Further investigation in cell culture suggested that cGP promoted the activity of IGF-1 when it was insufficient, but inhibited the activity of IGF-1 when it was excessive. Mathematical modelling revealed that the efficacy of cGP was a modulated IGF-1 effect via changing the binding of IGF-1 to its binding proteins, which dynamically regulates the balance between bioavailable and non-bioavailable IGF-1. Our data reveal a novel mechanism of auto-regulation of IGF-1, which has physiological and pathophysiological consequences and potential pharmacological utility.

  12. Diffuse large B cell lymphoma of thyroid as a masquerader of anaplastic carcinoma of thyroid, diagnosed by FNA: a case report

    Directory of Open Access Journals (Sweden)

    Dehghani Mehdi

    2006-01-01

    Full Text Available Abstract Background Both thyroid lymphoma and anaplastic carcinoma of thyroid present with rapidly growing mass in eldery patients. Anaplastic carcinoma has high mortality rate and combination of surgery, radiation therapy and multidrug chemotherapy are the best chance for cure. Prognosis of thyroid lymphoma is excellent and chemotherapy for widespred lymphoms and radiotherapy with or without adjuvant chemotherapy for tumors localized to the gland, are the treatment of choice. Case report This article reports a 70 year old man presenting with diffuse neck swelling and hoarseness of few weeks duration. Fine needle aspiration was done and reported as anaplastic carcinoma of thyroid which thyroidectomy was planned. The slides were sent for second opinion. After review, with initial diagnosis of anaplastic carcinoma versus lymphoma, immunocytochemical study was performed. Smears were positive for B cell markers and negative for cytokeratin, so with the impression of diffuse large B cell lymphoma, the patient received two courses of chemotherapy by which the tumor disappeared during two weaks. Conclusion Despite previous reports, stating easy diagnosis of high-grade thyroid lymphoma on the grounds of cytomorphological features we like to emphasize, overlapping cytologic features of the curable high grade thyroid lymphoma form noncurable anaplastic thyroid carcinoma and usefulness of immunocytochemistry to differentiate these two disease.

  13. Troponin T isoform expression is modulated during Atlantic Halibut metamorphosis

    Directory of Open Access Journals (Sweden)

    Llewellyn Lynda

    2007-06-01

    Full Text Available Abstract Background Flatfish metamorphosis is a thyroid hormone (TH driven process which leads to a dramatic change from a symmetrical larva to an asymmetrical juvenile. The effect of THs on muscle and in particular muscle sarcomer protein genes is largely unexplored in fish. The change in Troponin T (TnT, a pivotal protein in the assembly of skeletal muscles sarcomeres and a modulator of calcium driven muscle contraction, during flatfish metamophosis is studied. Results In the present study five cDNAs for halibut TnT genes were cloned; three were splice variants arising from a single fast TnT (fTnT gene; a fourth encoded a novel teleost specific fTnT-like cDNA (AfTnT expressed exclusively in slow muscle and the fifth encoded the teleost specific sTnT2. THs modified the expression of halibut fTnT isoforms which changed from predominantly basic to acidic isoforms during natural and T4 induced metamorphosis. In contrast, expression of red muscle specific genes, AfTnT and sTnT2, did not change during natural metamorphosis or after T4 treatment. Prior to and after metamorphosis no change in the dorso-ventral symmetry or temporal-spatial expression pattern of TnT genes and muscle fibre organization occurred in halibut musculature. Conclusion Muscle organisation in halibut remains symmetrical even after metamorphosis suggesting TH driven changes are associated with molecular adaptations. We hypothesize that species specific differences in TnT gene expression in teleosts underlies different larval muscle developmental programs which better adapts them to the specific ecological constraints.

  14. Study of contamination by 100 {mu}Ci of Sr 90 in the rat: clinical, hematological and osseous effects (appearance of osteosarcomas); Etude d'une contamination par 100 {mu}Ci de Sr 90 chez le rat: consequences cliniques, hematologiques et osseuses (apparition d'osteosarcomes)

    Energy Technology Data Exchange (ETDEWEB)

    Graf, B; Lafuma, J; Parmentier, C; Parmentier, N [Commissariat a l' Energie Atomique, Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires

    1968-07-01

    Clinical, hematological and osseous effects following an intramuscular injection of 100 {mu}Ci 90 Sr were studied in the rat. In spite of the magnitude of the injection and the resulting damage, the elimination of strontium could compare with what occurs after an injection at tracer doses. Comparing with the controls at the outcoming time, clinical monitoring mainly brought out a loss of body weight. Fairly early (20. - 30. day) there occurred severe hematological damage, especially on lymphocyte line, which subsided spontaneously. As foreseen, the anatomo-pathological survey of the early period showed bone and medullar lesions in the areas of enchondral ossification. In the late period, bone sarcomas occurred in nine animals out of ten. The outstanding histological type was osteogenic osteosarcomas; besides, two animals experienced bilateral tumors. (authors) [French] Les auteurs etudient les consequences cliniques, hematologiques et osseuses d'une contamination par 100 microcuries de Sr 90 injectes par voie intramusculaire chez le rat. Malgre l'importance de la contamination et les lesions consequentes, l'elimination du Sr 90 est comparable a celle que l'on observe apres injection de doses traceuses. La surveillance clinique ne met essentiellement en evidence, a la periode terminale, qu'une diminution du poids par rapport aux temoins. Les lesions hematologiques sont importantes, predominant sur la lignee lymphocytaire. Elles sont relativement precoces (20e - 30e jours) et regressent spontanement. La surveillance anatomo-pathologique de la periode precoce a montre, comme il etait previsible, des lesions osseuses et medullaires dans les zones d'ossification enchondrale. A la periode tardive, la survenue de sarcomes osseux a ete observee chez neuf animaux sur dix. Le type histologique predominant est l'osteosarcome osteogenique et il faut signaler egalement les tumeurs bilaterales observees chez deux animaux. (auteurs)

  15. Study of contamination by 100 {mu}Ci of Sr 90 in the rat: clinical, hematological and osseous effects (appearance of osteosarcomas); Etude d'une contamination par 100 {mu}Ci de Sr 90 chez le rat: consequences cliniques, hematologiques et osseuses (apparition d'osteosarcomes)

    Energy Technology Data Exchange (ETDEWEB)

    Graf, B.; Lafuma, J.; Parmentier, C.; Parmentier, N. [Commissariat a l' Energie Atomique, Fontenay-aux-Roses (France). Centre d' Etudes Nucleaires

    1968-07-01

    Clinical, hematological and osseous effects following an intramuscular injection of 100 {mu}Ci 90 Sr were studied in the rat. In spite of the magnitude of the injection and the resulting damage, the elimination of strontium could compare with what occurs after an injection at tracer doses. Comparing with the controls at the outcoming time, clinical monitoring mainly brought out a loss of body weight. Fairly early (20. - 30. day) there occurred severe hematological damage, especially on lymphocyte line, which subsided spontaneously. As foreseen, the anatomo-pathological survey of the early period showed bone and medullar lesions in the areas of enchondral ossification. In the late period, bone sarcomas occurred in nine animals out of ten. The outstanding histological type was osteogenic osteosarcomas; besides, two animals experienced bilateral tumors. (authors) [French] Les auteurs etudient les consequences cliniques, hematologiques et osseuses d'une contamination par 100 microcuries de Sr 90 injectes par voie intramusculaire chez le rat. Malgre l'importance de la contamination et les lesions consequentes, l'elimination du Sr 90 est comparable a celle que l'on observe apres injection de doses traceuses. La surveillance clinique ne met essentiellement en evidence, a la periode terminale, qu'une diminution du poids par rapport aux temoins. Les lesions hematologiques sont importantes, predominant sur la lignee lymphocytaire. Elles sont relativement precoces (20e - 30e jours) et regressent spontanement. La surveillance anatomo-pathologique de la periode precoce a montre, comme il etait previsible, des lesions osseuses et medullaires dans les zones d'ossification enchondrale. A la periode tardive, la survenue de sarcomes osseux a ete observee chez neuf animaux sur dix. Le type histologique predominant est l'osteosarcome osteogenique et il faut signaler egalement les tumeurs bilaterales observees chez deux animaux. (auteurs)

  16. Diagnosis and differential diagnosis of Graves' orbitopathy in MRI; Diagnose und Differenzialdiagnose der endokrinen Orbitopathie in der MRT

    Energy Technology Data Exchange (ETDEWEB)

    Daubner, D.; Spieth, S.; Engellandt, K.; Kummer, R. von [Universitaetsklinikum Carl Gustav Carus, Technische Universitaet Dresden, Abteilung Neuroradiologie, Institut und Poliklinik fuer Radiologische Diagnostik, Dresden (Germany)

    2012-06-15

    entzuendlichen Orbitaerkrankungen auch Tumoren. Dabei stellen der Pseudotumor orbitae (idiopathische, unspezifische orbitale Entzuendung), die Myositis oculi und das orbitale Lymphom wichtige Entitaeten dar, die anhand von Mustern (Lokalisation, Beteiligung orbitaler Strukturen und Signalveraenderungen) bildgebend in der MRT differenziert werden koennen. (orig.)

  17. Imaging of extradural spinal lesions; Bildgebung extraduraler Raumforderungen

    Energy Technology Data Exchange (ETDEWEB)

    Ahlhelm, F.; Schulte-Altedorneburg, G.; Naumann, N.; Reith, W. (Universitaetsklinikum des Saarlandes, Klinik fuer Diagnostische und Interventionelle Neuroradiologie, Homburg/Saar); Nabhan, A. (Universitaetsklinikum des Saarlandes, Homburg/Saar, Klinik fuer Allgemeine und Spezielle Neurochirurgie)

    2006-12-15

    There is a wide variety of spinal extradural tumors. In addition to real neoplasms, degenerative diseases, congenital abnormalities and inflammatory disorders can be causes of extradural masses. Due to the bony boundary of the spinal canal, both benign as well as malignant masses can cause progressive neurological deficits including paraplegia. Most of the spinal tumors are benign (hemangioma of the vertebral body, degenerative diseases). In younger patients congenital abnormalities and primary tumors of the spine have to be considered, whereas in adults the list of differential diagnoses should include secondary malignancies such as metastases and lymphomas as well as metabolic disorders such as osteoporotic vertebral compression fracture and Paget's disease. Cross-sectional imaging techniques such as magnetic resonance imaging (MRI) and computed tomography (CT) of the spine often help to make a specific diagnosis of extradural spinal lesions and represent important tools for tumor staging and preoperative evaluation. (orig.) Das Spektrum der spinalen extraduralen Tumoren ist sehr gross. Neben echten Neoplasien koennen auch degenerative Veraenderungen und Anlagestoerungen sowie entzuendliche Veraenderungen Ursachen einer extraduralen Raumforderung sein. Aufgrund der knoechernen Begrenzung des Spinalkanals koennen neben Malignomen auch benigne Tumoren und degenerative spinale Veraenderungen zu progredienten neurologischen Ausfallsymptomen (einschliesslich Querschnittsymptomatik) fuehren. Die ueberwiegende Mehrzahl der extraduralen Raumforderungen der Wirbelsaeule ist benigne (Haemangiom des Wirbelkoerpers, degenerative Erkrankungen). Bei jungen Patienten sind Anlagestoerungen und primaere Wirbelsaeulentumoren zu beruecksichtigen, wogegen beim Erwachsenen an sekundaere Malignome, wie Metastasen und Lymphome sowie eine metabolische Erkrankung, wie die osteoporotische Wirbelkoerpersinterungsfraktur oder der Morbus Paget, differenzialdiagnostisch gedacht werden

  18. Bone and bone marrow - nuclear medicine in the diagnosis of disorders of the hematopoetic system; Skelett und Knochenmark - nuklearmedizinische Diagnostik bei onkologischen und haematologischen Systemerkrankungen

    Energy Technology Data Exchange (ETDEWEB)

    Cremerius, U. [Technische Hochschule Aachen (Germany). Klinik fuer Nuklearmedizin

    1997-10-01

    Significant progress has been achieved during the last years regarding therapy of neoplastic and non-neoplastic diseases of the hematopoietic system by introduction of new therapeutic modalities like highdose chemotherapy, bone marrow and stem cell transplantation, interferon-therapy and others. Diagnosis is still based on biopsy and histopathology of bone marrow. Imaging methods, however, provided by radiology and nuclear medicine, are now increasingly employed to give an additional macroscopic view over morphological and functional changes of the entire bone marrow. Bone marrow scintigraphy either using radiocolloids or immunoscintigraphy against granulocyte-antigenes may be performed as an alternative or an addition to nuclear magnetic resonance imaging. Bone scintigraphy has been successful in the detection of additional bony lesions for more than two decades. Positron emission tomography using 18-fluorine-deoxyglucose has recently been employed as a new and promising tool also for assessment of bone marrow infiltration in malignant lymphomas. (orig.) [Deutsch] Die Therapie onkologischer und haematologischer Systemerkrankungen wie der malignen Lymphome, des Plasmozytoms und der Osteomyelofibrose hat in den letzten Jahren grosse Fortschritte durch die Anwendung neuer Therapiemodalitaeten (Hochdosischemotherapie, Knochenmark- und Stammzelltransplantation, Einsatz von Interferon u.a.) erfahren. Grundlage der Diagnostik ist nach wie vor die histologische Beurteilung des Knochenmarks nach Biopsie. Ergaenzend spielen bildgebende radiologische und nuklearmedizinische Verfahren zur makroskopischen Beurteilung morphologischer und funktioneller Veraenderungen des gesamten Knochenmarkraumes eine zunehmende Rolle. Die Knochenmarkszintigraphie mit Radiokolloiden bzw. die Knochenmarkimmunszintigraphie stellen hierbei wichtige Methoden alternativ oder ergaenzend zur Kernspintomographie dar. Die Skelettszintigraphie als bewaehrte Methode vermag zusaetzlich ossaere

  19. Diferenciação de células-tronco mesenquimais derivadas do tecido adiposo em cardiomiócitos

    Directory of Open Access Journals (Sweden)

    Pablo Herthel Carvalho

    2013-01-01

    Full Text Available FUNDAMENTO: O potencial de renovação e proliferação dos cardiomiócitos, in vivo, é pequeno, e por isso, o músculo cardíaco apresenta limitada capacidade de repor células perdidas. Na tentativa de minimizar os danos oriundos de lesões hipóxico-isquêmicas e daquelas que acometem o sistema de condução do coração, a terapia celular com células-tronco mesenquimais (MSC vem sendo utilizada, inclusive com cardiomiócitos diferenciados a partir de MSC. OBJETIVO: O presente trabalho comparou três protocolos distintos de indução de diferenciação objetivando a sugestão de um método viável para a diferenciação de maior número de células funcionais que expressem fenótipo cardiomiogênico. MÉTODOS: Culturas de MSC obtidas de tecido adiposo de ratos jovens da linhagem Lewis transgênicos para proteína verde fluorescente (GFP foram submetidos a três diferentes meios de diferenciação cardiogênica: Planat-Bérnard, 5-azacitidina e meio Planat-Bérnard + 5-azacitidina e observadas quanto a expressão de marcadores celulares cardíacos. RESULTADOS: Nos três protolocos utilizados observou-se formação da proteína alfa-actinina sarcomérica no citoesqueleto das células submetidas à diferenciação, expressão de conexina 43 na membrana nuclear e citoplasmática e formação de gap junctions, necessárias para a propagação do impulso elétrico no miocárdio, contudo, em nenhum protocolo foi observada contração espontânea das células submetidas à diferenciação cardiogênica. CONCLUSÃO: A indução com 5-azacitidina proporcionou diferenciação celular cadiomiogênica efetiva e similar à encontrada com o meio Planat-Bénard e, por ser um protocolo mais simples, rápido e com menor custo torna-se o método de eleição.

  20. New quality assurance program integrating ''modern radiotherapy'' within the German Hodgkin Study Group

    Energy Technology Data Exchange (ETDEWEB)

    Kriz, J.; Haverkamp, U.; Eich, H.T. [University of Muenster, Department of Radiation Oncology, Muenster (Germany); Baues, C.; Marnitz-Schulze, S. [University of Cologne, Department of Radiation Oncology, Koeln (Germany); Engenhart-Cabillic, R. [University of Marburg, Department of Radiation Oncology, Marburg (Germany); Herfarth, K. [University of Heidelberg, Department of Radiation Oncology, Heidelberg (Germany); Lukas, P. [University of Innsbruck, Department of Radiation Oncology, Innsbruck (Austria); Schmidberger, H. [University of Mainz, Department of Radiation Oncology, Mainz (Germany); Fuchs, M.; Engert, A. [University of Cologne, Department of Internal Medicine, Koeln (Germany)

    2017-02-15

    Field design changed substantially from extended-field RT (EF-RT) to involved-field RT (IF-RT) and now to involved-node RT (IN-RT) and involved-site RT (IS-RT) as well as treatment techniques in radiotherapy (RT) of Hodgkin's lymphoma (HL). The purpose of this article is to demonstrate the establishment of a quality assurance program (QAP) including modern RT techniques and field designs within the German Hodgkin Study Group (GHSG). In the era of modern conformal RT, this QAP had to be fundamentally adapted and a new evaluation process has been intensively discussed by the radiotherapeutic expert panel of the GHSG. The expert panel developed guidelines and criteria to analyse ''modern'' field designs and treatment techniques. This work is based on a dataset of 11 patients treated within the sixth study generation (HD16-17). To develop a QAP of ''modern RT'', the expert panel defined criteria for analysing current RT procedures. The consensus of a modified QAP in ongoing and future trials is presented. With this schedule, the QAP of the GHSG could serve as a model for other study groups. (orig.) [German] Nicht nur die Zielvolumendefinitionen haben sich von der Extended-Field- (EF-RT) ueber die Involved-Field- (IF-RT) bis zur Involved-Node- (IN-RT) und Involved-Site-Radiotherapie (IS-RT) weiterentwickelt. Auch die Radiotherapie(RT)-Techniken in der Behandlung von Patienten mit Hodgkin-Lymphom haben Aenderungen erfahren. Wir moechten aufzeigen, wie die Arbeit des Qualitaetssicherungsprogramms (QAP) innerhalb der Deutschen Hodgkin Studiengruppe (German Hodgkin Study Group [GHSG]) in der Aera der ''modernen RT'' hinsichtlich intensitaetsmodulierter RT (IMRT) und bildgefuehrter RT (IGRT), aber auch hinsichtlich moderner Felddefinitionen wie bei der IN-RT angepasst wurde. In der Aera der ''modernen RT'' wurde das QAP vom radiotherapeutischen Expertenpanel der GHSG im Rahmen einiger

  1. Les déterminants du statut “perdu de vue” chez les patients pris en charge pour cancer au Maroc: situation avant le Plan Cancer

    Science.gov (United States)

    Najdi, Adil; Berraho, Mohamed; Bendahhou, Karima; Obtel, Majdouline; Zidouh, Ahmed; Errihani, Hassan; Nejjari, Chakib

    2014-01-01

    Introduction Le cancer au Maroc représente un problème majeur de santé publique, sa prise en charge doit être globale, active et complète pour tous les patients. L'objectif de ce travail était d'estimer la fréquence des perdus de vue « PDV » en oncologie au Maroc durant la première année de suivi et de déterminer les facteurs associés à ce problème. Méthodes Par une étude rétrospective portant sur 2854 dossiers de malades hospitalisés dans les trois principaux centres d'oncologie au Maroc depuis janvier 2003 jusqu’à juin 2007 et concernant les cinq principales localisations de cancer au Maroc, nous avons cherché la date des dernières nouvelles des patients ayant un recul de 18 mois minimum afin de déterminer le statut de ces malades après un an de suivi. Résultats La moyenne d’âge était de 52±14 ans, une proportion féminine de 63%, les sujets actifs constituaient 28%, les mariés 71%, les analphabètes 51%, 70% des patients habitaient en milieu urbain et seulement 11% des malades disposaient d'une couverture sociale. La localisation cancéreuse la plus fréquente était le poumon (23,8%) suivie du colon-rectum (23,5%) puis le col (21,9%), le sein (20,4%) et les lymphomes (10,4%). Le taux des «PDV» à un an de suivi était de 48%, ce statut était significativement lié au sexe, à l’âge, au NSE et au statut matrimonial. Sur le plan médical, le statut «PDV» était lié à la localisation du cancer, au stade de diagnostic et au type de traitement reçu. Conclusion Notre étude a mis en évidence la grande ampleur du problème des PDV en cancérologie au Maroc ainsi que ces déterminants. Ces résultats incitent tous les acteurs dans le domaine de la cancérologie à collaborer ensemble pour prendre les mesures qui s'imposent pour y pallier PMID:25400850

  2. Neuropathological and neuroradiological aspects of acute disseminated encephalomyelitides (ADEM); Neuropathologische und neuroradiologische Aspekte akuter disseminierter Enzephalomyelitiden (ADEM)

    Energy Technology Data Exchange (ETDEWEB)

    Niedermayer, I.; Feiden, W. [Universitaet des Saarlandes, Homburg/Saar (Germany). Abt. fuer Neuropathologie; Deinzer, M. [Universitaet des Saarlandes, Homburg/Saar (Germany). Abt. Neuroradiologie; Moringlane, J.R. [Universitaet des Saarlandes, Homburg/Saar (Germany). Neurochirurgische Klinik

    2000-11-01

    Karzinommetastase oder ein primaer zerebrales Non-Hodgkin-Lymphom, gelegentlich auch eine ischaemische Hirngewebsnekrose oder ein Abszess vermutet wird. Diese Annahmen werden durch die subkortikale Lokalisation und die marginal betonte Anreicherung von Kontrastmittel unterstuetzt. Der bioptische Nachweis einer relativ frischen Markschaedigung und einer lymphozytaeren Entzuendungsreaktion bei relativer Unversehrtheit axonaler Strukturen macht die Diagnose einer akuten primaeren Entmarkungserkrankung wahrscheinlich. Die floride reaktive Astrogliose mit z.T. pleomorphen tumorverdaechtigen Reizformen der Astroglia kann so ausgepraegt sein, dass im Rahmen der intraoperativen Schnelldiagnostik ein Glioma in Erwaegung gezogen wird. Exemplarisch werden Befunde einer Serie 14 radiologisch und stereotaktisch-bioptisch dokumentierter ADEM vorgestellt und diskutiert. (orig.)

  3. Organ Visualization by Photoscanning Using Micro- and Macro-Aggregates of Radioalbumin; Examen d'Organes par Photoscintigraphie (avec des Micro-Agglomerats et des Macroagglomerats de Radioalbumine); Vizualizatsiya organov putem fotoskennirovaniya; Visualizacion de Organos por Fotoexploracion (Empleo de Micro y Macroagregados de Radioalbumina)

    Energy Technology Data Exchange (ETDEWEB)

    Taplin, G. V.; Johnson, D. E.; Dore, E. K.; Kaplan, H. S. [School of Medicine, University of California, Los Angeles (United States); Los Alamos County Harbor General Hospital, Torrance, CA (United States)

    1964-10-15

    Micro aggregates (10 - 20 nm) of human serum albumin I{sup 131} are shown to be superior to other agents for liver-spleen photoscanning. Radiation exposure to these organs is minimized and the test agent can be prepared with relative ease and simplicity. Also, the heart, stomach and salivary glands may be clearly visualized with the same material. The techniques and physiological basis for performing and interpreting scans of these organs are described. Their diagnostic value is illustrated. The physiological basis for using macro albumin aggregates (1 - 10 {mu}m) for visualization of the lungs is presented, along with typical scans in dogs. Toxicity studies and related pathophysiological investigations in animals demonstrate a wide margin of safety for using the large-particle test agents in man. Preliminary experiments in dogs indicate the feasibility of performing lung scans following the inhalation of an aerosol of the same material. This technique is simple, painless and entirely safe. Photoscans are presented from patients with a wide variety of pulmonary disorders. (author) [French] On a constate que les micro-agglomerats (10 a 20 nm) d'albumine de serum humain marquee avec {sup 131}I sont superieurs a toutes les autres substances pour la photoscintigraphie de la rate et du foie. Ils permettent de reduire au minimum la radioexposition de ces organes; en outre, leur preparation est relativement facile et simple. La m e m e substance permet d'explorer aussi bien le coeur, l'estomac et les glandes salivaires. Les auteurs exposent les methodes et les bases physiologiques d'execution et d'interpretation des scintigrammes de ces organes. Ils donnent des exemples de leur valeur pour le diagnostic. Les auteurs indiquent ensuite les arguments d'ordre physiologique qui militent en faveur de l'utilisation de macro-agglomerats (1 a 10 {mu}) de radioalbumine pour explorer les poumons et presentent des scintigrammes typiques faits sur des chiens. Les etudes de toxicite et

  4. Breath-hold technique in conventional APPA or intensity-modulated radiotherapy for Hodgkin's lymphoma. Comparison of ILROG IS-RT and the GHSG IF-RT

    Energy Technology Data Exchange (ETDEWEB)

    Kriz, Jan; Spickermann, Max; Lehrich, Philipp; Reinartz, Gabriele; Eich, Hans; Haverkamp, Uwe [University of Muenster, Department of Radiation Oncology, Muenster (Germany); Schmidberger, Heinz [University Mainz, Department of Radiation Oncology, Mainz (Germany)

    2015-09-15

    The present study addresses the role of intensity-modulated radiotherapy (IMRT) in contrast to standard RT (APPA) for patients with Hodgkin's lymphoma (HL) with a focus on deep inspiration breath-hold (DIBH) technique and a comparison between the International Lymphoma Radiation Oncology Group (ILROG) Involved Site Radiotherapy (IS-RT) versus the German Hodgkin Study Group (GHSG) Involved Field Radiotherapy (IF-RT). APPA treatment and 2 IMRT plans were compared for 11 patients with HL. Furthermore, treatment with DIBH versus free breathing (FB) and two different treatment volumes, i.e. IF-RT versus IS-RT, were compared. IMRT was planned as a sliding-window technique with 5 and 7 beam angles. For each patient 12 different treatment plans were calculated (132 plans). Following organs at risk (OAR) were analysed: lung, heart, spinal cord, oesophagus, female breast and skin. Comparisons of the different values with regard to dose-volume histograms (DVH), conformity and homogeneity indices were made. IS-RT reduces treatment volumes. With respect to the planning target volume (PTV), IMRT achieves better conformity but the same homogeneity. Regarding the D{sub mean} for the lung, IMRT shows increased doses, while RT in DIBH reduces doses. The IMRT shows improved values for D{sub max} concerning the spinal cord, whereas the APPA shows an improved D{sub mean} of the lung and the female breast. IS-RT reduces treatment volumes. Intensity-modulated radiotherapy shows advantages in the conformity. Treatment in DIBH also reduces the dose applied to the lungs and the heart. (orig.) [German] Ziel dieser Auswertung ist es, die konventionelle APPA-Feldanordnung mit der Intensitaetsmodulierten Radiotherapie (IMRT) bei Patienten mit Hodgkin-Lymphom (HL) zu vergleichen. Ein besonderer Fokus liegt hierbei auf der Bestrahlung in tiefer Inspiration und Atemanhaltetechnik (DIBH). Des Weiteren wurde die ''Involved-site''-Radiotherapie (IS-RT) der International

  5. A clinical example of extreme dose exposure for an implanted cardioverter-defibrillator. Beyond the DEGRO guidelines

    Energy Technology Data Exchange (ETDEWEB)

    Hristova, Yoana; Koehn, Janett; Preuss, Stefanie [Johann Wolfgang Goethe University Frankfurt, Department of Radiation Oncology, University Hospital, Frankfurt (Germany); Roedel, Claus; Balermpas, Panagiotis [Johann Wolfgang Goethe University Frankfurt, Department of Radiation Oncology, University Hospital, Frankfurt (Germany); German Cancer Research Center (DKFZ), Heidelberg (Germany); German Cancer Consortium (DKTK), Frankfurt am Main (Germany)

    2017-09-15

    ) stoeren. Aufgrund dessen erfolgte eine Aktualisierung der Leitlinien der DEGRO/DGK zur Strahlentherapie dieses Patientenkollektivs. Wir berichten von einem Patienten mit ICD-Implantat und kardialer Beteiligung eines T-lymphoblastischen Lymphoms, der u. a. eine Ganzkoerperbestrahlung mit 8 Gy und eine anschliessende konsolidierende Bestrahlung des Perikards mit 14 Gy sowie erneute Bestrahlungen in Rezidivsituation erhalten hat. Im Rahmen der Behandlung wurde die antitachyarrhythmische (ATA) Therapie ausgeschaltet und voruebergehend durch eine LifeVest ersetzt. Gemaess der aktuellen DEGRO-Leitlinie zur Bestrahlung von Patienten mit kardialen implantierten elektronischen Geraeten erfolgte die Einstufung des Patienten in die ''High-risk''-Gruppe. Ausserdem wurden regelmaessige telemetrische Abfragen des ICD-Geraets vor und nach Behandlung durchgefuehrt. Trotz fehlender Angabe des Herstellers bezueglich der erlaubten Kumulativdosis und Empfehlung der DEGRO ueber eine maximale Gesamtdosis <2 Gy, zeigte sich bei einer Gesamtdosis im Bereich des Geraets von >10 Gy in der ICD-Abfrage nach abgeschlossener Strahlentherapie eine unauffaellige Nachsorge mit regelrechten Messwerten fuer alle relevanten ICD-Parameter. Der Fall zeigt, dass bei Vermeidung einer direkten Bestrahlung der kardial implantierten elektronischen Geraete und bei Verwendung einer Energie von maximal 6 MV, eine strahleninduzierte Schaedigung weniger wahrscheinlich ist und vermieden werden koennte. (orig.)

  6. Veno-occlusive liver disease after infradiaphragmatic total lymphoid irradiation. A rare complication; Die Venenverschlusskrankheit der Leber nach infradiaphragmaler total lymphatischer Bestrahlung. Eine seltene Nebenwirkung

    Energy Technology Data Exchange (ETDEWEB)

    Bischof, M.; Zierhut, D.; Gutwein, S.; Wannenmacher, M. [Heidelberg Univ. (DE.) Abt. fuer Klinische Radiologie - Schwerpunkt Strahlentherapie; Hansmann, J. [Heidelberg Univ. (DE.) Abt. fuer Radiologische Diagnostik; Stremmel, W.; Mueller, M. [Heidelberg Univ. (DE). Abt. Innere Medizin 4 (Schwerpunkt Gastroenterologie)

    2001-06-01

    -jaehrigen Patienten mit einem zentrozytisch-zentroblastischen Non-Hodgkin-Lymphom, Stadium IA (Lokalisation: Linke Leiste) wurde die gesamte Abdomen- und Beckenregion ('abdominelles Bad') bestrahlt. Bei einer woechentlichen Fraktionierung von fuenfmal 1,5 Gy wurde eine Gesamtdosis von 30 Gy appliziert. Zum Schutz der Risikoorgane wurden Nierenbloecke nach 13,5 Gy und Leberbloecke nach 25 Gy eingesetzt. Waehrend der letzten beiden Therapietage kam es zur Verschlechterung des Allgemeinzustandes des Patienten mit Gewichtszunahme, Vergroesserung des Bauchumfanges, Dyspnoe und einem Anstieg der Leberwerte. Die weiterfuehrende Diagnostik ergab eine Hepatosplenomegalie mit ausgepraegter Aszitesbildung und einen erhoehten portosystemischen Druckgradienten. Im Leberbiopsat wurde eine Venenverschlusskrankheit gefunden. Innerhalb 1 Woche nach Anlage eines transjungulaeren intrahepatischen portosystemischen Stent-Shunts (TIPSS), Vollheparinisierung und unter Diuretikagabe war der Patient beschwerdefrei. Die Leberwerte sind im Normbereich. Schlussfolgerung: Die Venenverschlusskrankheit der Leber (VOD) ist eine sehr seltene Nebenwirkung bei der abdominellen Bestrahlung nicht vorbehandelter follikulaerer Keimzentrumslymphome. Bei Oberbauchbeschwerden, Anstieg der Leberenzyme sowie Aszitesbildung, insbesondere in einem Zeitraum von bis zu 4 Monaten nach Therapieabschluss, muss an diese Komplikation gedacht werden. Genese, Diagnostik und Therapie der Venenverschlusskrankheit der Leber werden im Literaturueberblick praesentiert. (orig.)

  7. Radiation-induced camptocormia and dropped head syndrome. Review and case report of radiation-induced movement disorders

    Energy Technology Data Exchange (ETDEWEB)

    Seidel, Clemens; Kuhnt, Thomas; Kortmann, Rolf-Dieter; Hering, Kathrin [Leipzig University, Department of Radiotherapy and Radiation Oncology, Leipzig (Germany)

    2015-10-15

    Form von ''Kamptokormie'' und ''Dropped Head Syndrom'' (DHS) verstaerkt wissenschaftliche Beachtung gefunden. Die Kamptokormie ist durch zunehmende Flexion des Oberkoerpers beim Gehen bei wenig beeintraechtigtem aufrechtem Stand charakterisiert. Das DHS imponiert durch eine Schwaeche der Nackenmuskulatur, die zu erschwerter Kopfhebung fuehrt. In schweren Faellen ist bei der Kamptokormie das Gehen stark beeintraechtigt und beim DHS das Kinn auf der Brust nahezu fixiert. Viele Erkrankungen koennen eine Kamptokormie verursachen, insbesondere neuromuskulaere Erkrankungen und Basalganglienerkrankungen (z. B. Morbus Parkinson). Zudem sind in der Literatur Berichte ueber strahleninduzierte Kamptokormie und DHS vorhanden. In einer systematischen Recherche in PubMed mit den Begriffen ''camptocormia'', ''dropped head syndrome'', ''radiation-induced movment disorder'', ''radiation-induced myopathy'', ''radiation-induced neuropathy'' wurden alle Publikationen zu diesen Themen erfasst und mit dem Ziel analysiert, strahleninduzierte Bewegungsstoerungen und die verwendeten Bestrahlungstechniken naeher zu charakterisieren. Zudem beschreiben wir den Fall eines Patienten, der 23 Jahre nach Bestrahlung eines Non-Hodgkin-Lymphoms des Abdomens eine erhebliche, schmerzhafte Kamptokormie entwickelte. Es wurden 9 Fallberichte zu radiogenem DHS (n = 45 Patienten) und 3 Fallberichte (n = 3 Patienten) zu radiogener Kamptokormie gefunden. Die ueberwiegende Anzahl der beschriebenen Faelle (40/45 Patienten) trat > 15 Jahre nach Bestrahlung auf, ueberwiegend von Hodgkin-Lymphomen mit ausgedehnten Bestrahlungsfeldern. Der Einsatz ausgedehnter Bestrahlungsfelder unter multisegmentalem Einschluss von Wirbelsaeule und paraspinaler Muskulatur kann zum Auftreten von DHS nach Bestrahlung der Nackenmuskulatur und zu Kamptokormie nach Bestrahlung der Rueckenstrecker

  8. Novel radiotherapy techniques for involved-field and involved-node treatment of mediastinal Hodgkin lymphoma. When should they be considered and which questions remain open

    Energy Technology Data Exchange (ETDEWEB)

    Lohr, Frank; Koeck, Julia; Abo-Madyan, Yasser [University of Heidelberg, Department of Radiation Oncology, University Medical Center Mannheim, Mannheim (Germany); Georg, Dietmar; Knaeusl, Barbara; Dieckmann, Karin [Medical University Vienna/AKH Vienna, Department of Radiation Oncology, Comprehensive Cancer Center, Vienna (Austria); Medical University Vienna/AKH Vienna, Christian Doppler Laboratory for Medical Radiation Research for Radiation Oncology, Comprehensive Cancer Center, Vienna (Austria); Cozzi, Luca [Medical Physics Unit, Oncology Institute of Southern Switzerland, Bellinzona (Switzerland); Eich, Hans Theodor [University Hospital, Department of Radiotherapy, Muenster (Germany); Weber, Damien C. [Paul Scherrer Institute, University of Bern, Center for Proton Therapy, Bern (Switzerland); Fiandra, Christian; Ricardi, Umberto [University of Torino, Radiation Oncology Unit, Department of Oncology, Turin (Italy); Mueller, Rolf-Peter [University of Cologne, Department of Radiation Oncology, Cologne (Germany); Engert, Andreas [University of Cologne, Department of Medical Oncology, Cologne (Germany)

    2014-10-15

    . (orig.) [German] Das Hodgkin-Lymphom (HL) ist eine Erkrankung mit hohen Heilungsraten. Die Verringerung von Spaetkomplikationen und Zweittumoren wird daher immer wichtiger. Zielvolumenkonzepte der Strahlentherapie (RT) veraendern sich gegenwaertig und Strahlentherapietechniken entwickeln sich sehr schnell weiter. Diese Uebersichtsarbeit stellt dar, inwiefern die Zielvolumenreduktion hin zum Involved-node(IN)-Konzept und hochentwickelte Strahlentherapietechniken wie die intensitaetsmodulierte Strahlentherapie (IMRT) und Protonentherapie, im Vergleich zu Involved-field(IF)-Konzept und 3-D-konformaler Strahlentherapie (3D-RT), die Belastung von Risikoorganen (OAR) mit hohen Dosen reduzieren koennen und welche Fragen in diesem Kontext noch geklaert werden muessen. Obwohl kein Vergleich aller verfuegbaren Techniken auf identischen Patientendatensaetzen existiert, entsteht folgendes Bild: Fortgeschrittene Dosisberechnungsalgorithmen (z. B. convolution-superposition/Monte Carlo) sollten im Rahmen der Behandlung des mediastinalen HL zur Anwendung kommen. INRT reduziert unter allen Bedingungen die behandelten Volumina im Vergleich zur IFRT, wobei die Hoehe des Vorteils von der jeweiligen INRT-Definition abhaengt. Die Anzahl der Patienten, die deutlich von hochkonformalen Techniken wie IMRT gegenueber der 3D-RT hinsichtlich der OAR-Belastung profitiert, ist bei INRT geringer. Die Konsequenz groesserer Volumina, die bei modernen Techniken mit eher isotroper Strahlanordnung mit niedrigen Dosen belastet werden, ist unklar. Die Art der verwendeten IMRT-Technik (statisch/Rotation) ist von geringer Relevanz. Alle fortgeschrittenen Photonentechniken resultieren in den gleichen Vorteilen und Nachteilen. Daher muss nur die Modulationstiefe abhaengig von den individuellen Behandlungszielen gewaehlt werden. Die Bestrahlung in tiefer Inspiration wird gegenwaertig evaluiert. Protonentherapie kann theoretisch bei hervorragender Hochdosiskonformalitaet die applizierte Integraldosis reduzieren

  9. Apport diagnostique de la cervicotomie exploratrice: étude rétrospective de 300 cas

    Science.gov (United States)

    Darouassi, Youssef; Chihani, Mehdi; Touati, Mohamed Mliha; Ammar, Haddou; Bouaity, Brahim

    2015-01-01

    Les tuméfactions cervicales représentent un motif fréquent de consultation, et les adénopathies en constituent l’étiologie la plus fréquente. L'examen clinique et les bilans paracliniques permettent, dans la majorité des cas de retrouver une étiologie. Néanmoins certaines de ces tuméfactions restent d'origine non précisée, portant donc l'indication d'une cervicotomie exploratrice. Il s'agit d'une étude rétrospective d'une série de 300 cas de tuméfactions cervicales isolées colligées au service d'ORL de l'hôpital militaire Avicenne de Marrakech entre 2001 et 2014. Tous nos patients ont bénéficié d'une cervicotomie exploratrice avec étude anatomo-pathologique. L’âge des patients varie entre 1 et 76 ans avec un âge moyen de 32,57 ans et une légère prédominance masculine de 52%. La symptomatologie qui a motivé une consultation chez 81% des patients était la tuméfaction latérocervicale. La localisation la plus fréquente était sous mandibulaire (33,34%). Les tuméfactions d'installation progressive ont été retrouvées chez 93,34% des patients. Les principales étiologies retrouvées dans notre étude après examen anatomopathologique étaient de deux types: soit d'origine ganglionnaire dominées par la tuberculose ganglionnaire cervicale (53,66%), le lymphome malin non hodgkinien (6,66%), les adénites réactionnelles non spécifiques (4,66%), la maladie deHodgkin (4,33%) et les métastases ganglionnaires cervicales (3,33%); soit d'origine non ganglionnaire dont le lipome cervicale (17,66%), les kystes branchiaux (6%), les kystes du tractus thyréoglosse (1,66%) et le lymphangiome kystique (1,66%). A la lumière des résultats obtenus et des données de la littérature, nous allons discuter l'intérêt et l'utilité de la cervicotomie exploratrice dans le diagnostic étiologique des tuméfactions cervicales lorsque les examens cliniques et paracliniques ne sont pas concluants, et ainsi d'analyser les aspects

  10. The Use of Technetium-99m as a Clinical Scanning Agent for Thyroid, Liver and Brain; Utilisation du {sup 99m}Tc comme Agent d'Exploration Clinique de la Thyroide, du Foie et du Cerveau; Ispol'zovanie Tc{sup 99m} kak klinicheskogo agenta pri skennirovanii shchitovidnoj zhelezy, pecheni i mozga; Empleo del {sup 99m}Tc como Agente para la Exploracion Clinica de la Tiroides, el Higado y el Cerebro

    Energy Technology Data Exchange (ETDEWEB)

    Harper, P. V.; Lathrop, K. A.; McCardle, R. J.; Andros, G. [Argonne Cancer Research Hospital and Department of Surgery, University of Chicago Hospitals and Clinics, Chicago, IL (United States)

    1964-10-15

    habituelle ({sup 99m}TcO{sub 4}{sup -}), il se repartit dans le corps d'une facon tres semblable a CIO{sub 4}{sup -} et I{sup -}, c'est-a-dire qu'il est rapidement disperse dans l'espace extra-cellulaire et accumule selectivement par la thyroiede, l'estomac et les glandes salivaires. Les donnees fournies par les excreta indiquent que la periode biologique est d'environ deux jours. On peut faire d'excellents scintigrammes de la thyroiede; avec une irradiation evaluee a 100 mrad pour la thyroiede, et a 5 mrad pour l'ensemble du corps, une demi-heure a une heure apres administration de 1 mc de {sup 99m}TcO{sub 4}{sup -}, ce qui represente un tres grand progres par rapport a l'utilisation de {sup 131}I. TcO{sub 4} ne traverse pas librement la barriere sang-cerveau, de sorte que l'on a obtenu des scintigrammes spectaculaires du cerveau avec un temps de balayage de 2 a 5 min grace au taux de comptage eleve fourni par des doses de 5 a 10 me de 99mTc. Comme le thiocyanate pentavalent se dissout dans une emulsion de corps gras, {sup 99m}TcO{sub 4}{sup -} se localise en grande partie dans le foie; la aussi, le taux de comptage eleve permet des explorations rapides avec une meilleure resolution. On espere qu'il sera possible de faite de nouveaux progres avec ce radioisotope grace a l'utilisation de sondes plus efficaces et a une manipulation plus poussee des parametres biologiques et chimiques. (author) [Spanish] El {sup 99m}Tc es uno de los isotopos que mas ventajas ofrecen para la exploracion cen- telleografica. Emite rayos gamma limpios de 140 keV (9% de conversion) sin radiacion corpuscular, tiene un periodo fisico de 6 h y puede obtenerse facilmente a un precio razonalbe como descendiente del {sup 99}Mo, (periodo: 2,7 d) del que se separa sin dificultad en una columna de alumina. En su forma usual ({sup 99m}TcO{sub 4}{sup -}) se distribuye por el cuerpo de manera muy parecida al CIO{sub 4}{sup -} y al I{sup -}, penetra rapidamente en el espacio extra- celular y es captado

  11. Lesões perinatais em bovinos na intoxicação experimental por Ateleia glazioviana (Leg.Papilionoideae Perinatal lesions in cattle experimentally poisoned by Ateleia glazioviana (Leg. Papilionoideae

    Directory of Open Access Journals (Sweden)

    Maria del Carmen García y Santos

    2004-12-01

    sarcomers. Mild glycogen storage was observed in a control calf.

  12. Diferenciação de células-tronco mesenquimais derivadas do tecido adiposo em cardiomiócitos Differentiation of adipose tissue-derived mesenchymal stem cells into cardiomyocytes

    Directory of Open Access Journals (Sweden)

    Pablo Herthel Carvalho

    2013-01-01

    Full Text Available FUNDAMENTO: O potencial de renovação e proliferação dos cardiomiócitos, in vivo, é pequeno, e por isso, o músculo cardíaco apresenta limitada capacidade de repor células perdidas. Na tentativa de minimizar os danos oriundos de lesões hipóxico-isquêmicas e daquelas que acometem o sistema de condução do coração, a terapia celular com células-tronco mesenquimais (MSC vem sendo utilizada, inclusive com cardiomiócitos diferenciados a partir de MSC. OBJETIVO: O presente trabalho comparou três protocolos distintos de indução de diferenciação objetivando a sugestão de um método viável para a diferenciação de maior número de células funcionais que expressem fenótipo cardiomiogênico. MÉTODOS: Culturas de MSC obtidas de tecido adiposo de ratos jovens da linhagem Lewis transgênicos para proteína verde fluorescente (GFP foram submetidos a três diferentes meios de diferenciação cardiogênica: Planat-Bérnard, 5-azacitidina e meio Planat-Bérnard + 5-azacitidina e observadas quanto a expressão de marcadores celulares cardíacos. RESULTADOS: Nos três protolocos utilizados observou-se formação da proteína alfa-actinina sarcomérica no citoesqueleto das células submetidas à diferenciação, expressão de conexina 43 na membrana nuclear e citoplasmática e formação de gap junctions, necessárias para a propagação do impulso elétrico no miocárdio, contudo, em nenhum protocolo foi observada contração espontânea das células submetidas à diferenciação cardiogênica. CONCLUSÃO: A indução com 5-azacitidina proporcionou diferenciação celular cadiomiogênica efetiva e similar à encontrada com o meio Planat-Bénard e, por ser um protocolo mais simples, rápido e com menor custo torna-se o método de eleição.BACKGROUND: Cardiomyocytes have small potential for renovation and proliferation in vivo. Consequently, the heart muscle has limited capacity of self-renewal. Mesenchymal stem cells (MSC therapy, as well

  13. Diferenciação de células-tronco mesenquimais derivadas do tecido adiposo em cardiomiócitos Differentiation of adipose tissue-derived mesenchymal stem cells into cardiomyocytes

    Directory of Open Access Journals (Sweden)

    Pablo Herthel Carvalho

    2012-01-01

    Full Text Available FUNDAMENTO: O potencial de renovação e proliferação dos cardiomiócitos, in vivo, é pequeno, e por isso, o músculo cardíaco apresenta limitada capacidade de repor células perdidas. Na tentativa de minimizar os danos oriundos de lesões hipóxico-isquêmicas e daquelas que acometem o sistema de condução do coração, a terapia celular com células-tronco mesenquimais (MSC vem sendo utilizada, inclusive com cardiomiócitos diferenciados a partir de MSC. OBJETIVO: O presente trabalho comparou três protocolos distintos de indução de diferenciação objetivando a sugestão de um método viável para a diferenciação de maior número de células funcionais que expressem fenótipo cardiomiogênico. MÉTODOS: Culturas de MSC obtidas de tecido adiposo de ratos jovens da linhagem Lewis transgênicos para proteína verde fluorescente (GFP foram submetidos a três diferentes meios de diferenciação cardiogênica: Planat-Bérnard, 5-azacitidina e meio Planat-Bérnard + 5-azacitidina e observadas quanto a expressão de marcadores celulares cardíacos. RESULTADOS: Nos três protolocos utilizados observou-se formação da proteína alfa-actinina sarcomérica no citoesqueleto das células submetidas à diferenciação, expressão de conexina 43 na membrana nuclear e citoplasmática e formação de gap junctions, necessárias para a propagação do impulso elétrico no miocárdio, contudo, em nenhum protocolo foi observada contração espontânea das células submetidas à diferenciação cardiogênica. CONCLUSÃO: A indução com 5-azacitidina proporcionou diferenciação celular cadiomiogênica efetiva e similar à encontrada com o meio Planat-Bénard e, por ser um protocolo mais simples, rápido e com menor custo torna-se o método de eleição.BACKGROUND: Cardiomyocytes have small potential for renovation and proliferation in vivo. Consequently, the heart muscle has limited capacity of self-renewal. Mesenchymal stem cells (MSC therapy, as well

  14. Analyses of patterns-of-failure and prognostic factors according to radiation fields in early-stage Hodgkin lymphoma

    Energy Technology Data Exchange (ETDEWEB)

    Krebs, Lorraine; Guillerm, Sophie; Menard, Jean; Hennequin, Christophe; Quero, Laurent [Saint Louis Hospital, Radiation Oncology Department, Paris (France); Amorin, Sandy; Brice, Pauline [Saint Louis Hospital, AP-HP, Hematooncology Department, Paris (France)

    2017-02-15

    des Hodgkin-Lymphoms (HL) reduziert. Der aktuelle Standard in der Behandlung besteht fuer die meisten HL-Patienten im Fruehstadium aus einer kombinierten Therapie. Ziel dieser Studie war es, die Stellen der Rezidive in Abhaengigkeit von den RT-Zielvolumina zu analysieren. Zwischen 1987 und 2011 wurden 427 HL-Patienten in Stadium I/II in unserer Institution mit einer RT mit oder ohne Chemotherapie behandelt. Die retrospektive Untersuchung umfasste 67 Patienten mit einem Rezidiv. Die meisten Patienten wiesen einen nodulaer-sklerosierenden Subtyp (86 %) und/oder ein Stadium II (75,9 %) auf. Von den Patienten hatten 21 % ein ''Bulky disease'' und 56 % eine unguenstige Prognose gemaess der Definition der EORTC (European Organization for Research and Treatment of Cancer) oder der LYSA (The Lymphoma Study Association). Eine kombinierte Therapie wurde 91 % der Patienten verabreicht. Bei allen Patienten wurde eine RT mit einer Dosis zwischen 20 und 45 Gy (mean =34 ± 5,3 Gy) durchgefuehrt. Eine Involved-Field-RT (IF-RT) kam bei 59 % der Patienten zum Einsatz. Die durchschnittliche Zeit zwischen der Diagnostik und dem Auftreten der Rezidive betrug 4,2 Jahre (Spanne 0,3-24,5 Jahre). Die Rezidive traten bei 53 % der Patienten ausserhalb des RT-Zielvolumens auf und waren bei Patienten mit einer guenstigen Prognose haeufiger. Rezidive innerhalb des RT-Zielvolumens waren mit einem ''Bulky disease'' assoziiert. Rezidive traten bei Patienten mit guenstiger Prognose spaeter auf als bei Patienten mit unguenstiger Prognose (3,5 vs. 2,9 Jahre; p = 0,5). In multivariater Analyse waren sowohl die Dosis als auch die Groesse der RT-Volumina nicht praediktiv fuer ein Rezidiv im Bestrahlungsfeld (jeweils p = 0,25 und p = 0,8), sondern nur das Bestehen eines ''Bulky disease'' (p = 0,018). Bei den Patienten mit einem ''Bulky disease'' sind die RT-Dosis und die RT-Volumina nicht praediktiv fuer die Verhinderung eines

  15. Patterns of failure of diffuse large B-cell lymphoma patients after involved-site radiotherapy

    Energy Technology Data Exchange (ETDEWEB)

    Holzhaeuser, Eva; Berlin, Maximilian; Bezold, Thomas; Mayer, Arnulf; Schmidberger, Heinz [University Medical Center Mainz, Department of Radiation Oncology and Radiotherapy, Mainz (Germany); Wollschlaeger, Daniel [University Medical Center Mainz, Institute for Medical Biostatistics, Epidemiology and Informatics, Mainz (Germany); Hess, Georg [University Medical Center Mainz, Department of Internal Medicine, Mainz (Germany)

    2017-12-15

    no marginal failures occurred. The concept of IS will likely reduce the risk for late sequelae of RT. (orig.) [German] Die konsolidierende Radiotherapie (RT) in Kombination mit einer Chemoimmuntherapie stellt eine hocheffiziente Therapiemethode in der Behandlung des diffusen grosszelligen B-Zell-Lymphoms (DLBCL) dar. Die vorliegende retrospektive Analyse evaluiert die Effektivitaet und Sicherheit des Volumen- und Dosiskonzepts der ''Involved-site''-Radiotherapie (ISRT). Wir identifizierten 60 Patienten mit histologisch gesichertem DLBCL im Stadium I-IV, die zwischen Januar 2005 und Dezember 2015 mit einer Chemoimmuntherapie und konsolidierender ISRT behandelt wurden. Progressionsfreies (PFS) und Gesamtueberleben (OS) wurden mittels Kaplan-Meier-Methode dargestellt und univariate Analysen mittels Log-rank-Test und Mann-Whitney-U-Test erhoben. Nach einer initialen Chemoimmuntherapie (ueberwiegend R-CHOP; Rituximab, Cyclophosphamid, Doxorubicin, Vincristin und Prednisolon) erzielten 19 Patienten (36 %) eine komplette (CR) und 34 (64 %) eine partielle Remission (PR) oder weniger. Ausgeschlossen wurden 7 Patienten (12 %) mit einem Progress nach Chemoimmuntherapie. Alle Patienten erhielten eine ISRT mit 40 Gy Gesamtdosis. Nach einer medianen Nachbeobachtungszeit von 44 Monaten waren 79 % der Patienten erkrankungsfrei, waehrend 21 % ein Rezidiv oder einen systemischen Progress erlitten oder verstarben. Alle Patienten mit CR nach Chemoimmuntherapie blieben nach konsolidierender ISRT in CR. Bei 2 Patienten mit PR nach Chemoimmuntherapie trat ein Rezidiv an Stelle der initialen Laesion innerhalb des IS-Planungszielvolumens (PTV) auf. Feldrandrezidive wurden nicht beobachtet. Ein signifikant verbessertes PFS zeigten ein Ann-Arbor-Stadium I/II im Vergleich zu Stadium III/IV (93 % vs. 65 %; p ≤ 0,021) sowie ein internationaler prognostischer Index (IPI) von 0 oder 1 verglichen mit 2-5 (100 % vs. 70 %; p ≤ 0,031). Der Post-Chemoimmuntherapie-Status einer CR

  16. Scanning of Bone Marrow in Haematopoietic Disorders; Gammagraphie de la Moelle Osseuse dans les Troubles Hematopoietiques; Skennirovanie kostnogo mozga pri gematopoehticheskikh narusheniyakh; Exploracion de la Medula Osea en Casos de Trastornos Hematopoyeticos

    Energy Technology Data Exchange (ETDEWEB)

    Kniseley, R. M.; Andrews, G. A.; Edwards, C. L.; Tanida, R. [Oak Ridge Institute of Nuclear Studies, TN (United States)

    1964-10-15

    , polyglobulie vraie, myelofibrose, myelomes et lymphomes. Etant donne l'activite reticuloendotheliale dans le foie et la rate, la structure medullaire est obscurcie au milieu du tronc. Les vertebres, les disques intervertebraux, le bassin et les os longs apparaissent tres nettement ainsi que. - dans le thorax - le sternum et les vertebres thoraciques. On a aussi releve des lesions focales. En raison du mouvement respiratoire, on ne distingue pas les diverses cotes. Il a ete possible de mettre les scintigrammes en correlation avec des biopsies par aspiration et des scintigrammes lineaires. Comrrte il faut des doses de {sup 198}Au relativement importantes, on etudie actuellement certains autres radioisotopes. On essaie un appareil perfectionne de scintigraphie de l'ensemble du corps en vue d'obtenir des scintigrammes plus pratiques. (author) [Spanish] La centelleo- grafia puede constituir una ayuda valiosa para evaluar el tamaflo y la distribucion de la medula hematopoyetica, operacion dificil de realizar por aspiracion o por biopsia. Con el centelleografo del Oak Ridge National Laboratory (colimador de oro-wolframio enfocado, de 61 canales) los autores han podido delinear claramente la medula inyectando oro-198 coloidal por vfa endovenosa, ya que se sabe que la funcion reticuloendotelial de la medula esta relacionada con zonas de hematopoyesis. Han sometido a exploracion gammagrafica a pacientes con funcion hematopoyetica normal y a otros con diversos trastornos de la sangre: lesiones focales de la medula, leucemia aguda o cronica, policitemia vera, mielofibrosis, mieloma multiple y linfoma. La actividad reticuloendotelial del higado y del bazo no permiten distinguir bien la medula en la parte central del tronco. En los centelleogramas se perciben claramente las vertebras, los discos intervertebrales, la pelvis y los huesos largos y, en el torax, el esternon y las vertebras toracicas. Se han hallado tambien lesiones focales. Los movimientos respiratorios no permiten ver

  17. Selective Neoplasm Localization with Mercury-197 Neohydrin; Localisation Selective de Neoplasmes a l'aide de la Neohydrine Marquee avec {sup 197}hg; Obnaruzhenie opukholej s pomoshch'yu neogidrina, mechennogo rtut'yu-197; Localizacion Selectiva de Neoplasmas con Neohidrina - {sup 197}hg

    Energy Technology Data Exchange (ETDEWEB)

    Sodee, D. B. [Doctors Hospital and Renner Clinic Foundation, Cleveland Heights, OH (United States)

    1964-10-15

    confirmes dans 96% des cas par le diagnostic final. La scintigraphie etait toujours faite avant tous les autres tests. L'application de cette methode de scintigraphie du cerveau a permis, en outre, de constater que la neohydrine marquee avec {sup 197}Hg etait localisee aussi bien dans les lymphomes que dans les carcinomes. Il semble y avoir depot selectif de la substance radioactive au niveau intercellulaire. Les zones de fixation accrue de la radioactivite peuvent etre aisement delimitees avec des agents scintigraphiques courants. Des essais sur 88 patients on montre que la neohydrine marquee avec {sup 197}Hg etait egalement utile comme agent de detection pour differencier les tumeurs des yeux; enfin, on a constate tout recemment qu'elle se concentrait dans les tumeurs rhino-pharyngiennes, que l'on pouvait alors delimiter par photoscintigraphie. La quantite de neohydrine marquee avec {sup 197}Hg necessaire a une scintigraphie du cerveau delivre au reins une dose de 3 rad, contre 70 rad pour la neohydrine marquee avec {sup 203}Hg, Du fait de la grande efficacite de comptage et de la facilite de collimation, {sup 197}Hg convient mieux que tous les autres agents classiques de diagnostic par scintigraphie. (author) [Spanish] El autor ensayo como agente de exploracion el {sup 197}Hg, emisor de rayosX y gamma de baja energia (periodo: 2,7 d; rayos X de conversion: 69keV; rayos gamma: 77keV). Quinientos pacientes, que presentaban sintomas de afecciones neuroquirurgicas, fueron examinados mediante neohidrina-{sup 197}Hg. Aplicando tecnicas de fotoexploracion que revelan tanto las lesiones vasculares como los tumores, se comprobo que entre los resultados asi obtenidos y el diagnostico definitivo habla una correlacion del 96%. Ese procedimiento de examen se aplico antes de proceder a las demas pruebas diagnosticas Como resultado de la aplicacion de ese procedimiento de exploracion del cerebro, el autor descubrio localizaciones de neohidrina-{sup 197}Hg en linfomas y carcinomas. Al

  18. Carcinogenesis by Fast Neutrons Relative to X-Rays in Mice; Carcinogenese chez les Souris sous l'Effet des Neutrons Rapides et des Rayons X; Sravnitel'naya chastota vozniknoveniya rakovykh opukholej u myshej pri obluchenii bystrymi nejtronami i rentgenovskimi luchami; Accion Carcinogenica Comparada de los Neutrones Rapidos y de los Rayos X en el Raton

    Energy Technology Data Exchange (ETDEWEB)

    Cole, L. J.; Nowell, P. C. [Division of Biological and Medical Sciences, U.S. Naval Radiological Defense Laboratory, San Francisco, CA (United States); Department of Pathology, School of Medicine, University of Pennsylvania, Philadelphia, PA (United States)

    1964-05-15

    ). Parmi les souris du Groupe I, sacrifiees 12 a 16 mois apres l'exposition, 75% presentaient des hepatomes; ce taux atteignait 92% chez les souris du Groupe II. Par contre, des tumeurs du foie se sont produites chez 14% des souris exposees seulement aux neutrons (Groupe V) et chez 2,4% des souris exposees a une dose unique (500 rad) de rayons X de 250 kVcrete. On a observe des neoplasmes du rein chez pres de 100% des souris du Groupe IV, alors que ces lesions ont ete peu frequentes chez les souris temoins. Les auteurs etudient Inverted-Exclamation-Mark ' induction de ces neoplasmes sous l'effet de l'exposition aux neutrons et leur developpement sous l'action des agent employes pour stimuler la proliferation. En ce qui concerne l'induction de neoplasmes du rein chez les souris, les donnees indiquent un coefficient de puissance d'environ 2 pour les neutrons de fission par rapport aux rayons X de 250 kV-crete. Pour ce qui est de l'apparition de lymphomes dans cette lignee, leur frequence a ete moins importante chez les souris exposees aux neutrons (11%) que chez les sujets exposes aux rayons X (29%). (author) [Spanish] Los autores sometieron ratones jovenes adultos de la variedad LAF a una exposicion subletal unica a neutrones de fision, tratandolos de la siguiente forma: Grupo I: 195 a 199 rad, seguida de una sola inyeccion subcutanea de CCl{sub 4}, un mes despues de la exposicion; Grupo II: inyeccion de CCl{sub 4} aplicada un dia antes de la irradiacion neutronica (280 y 329 rad); Grupo III: inyeccion de CCl{sub 4} sin irradiacion; Gmpo IV: nefrectomfa unilateral un dia antes de la irradiacion (320 y 328 rad); Grupo V: irradiacion neutronica exclusivamente (200 y 320 rad). Al sacrificar los sujetos entre 12 y 16 meses a contar de la irradiacion, se encontraron hepatomas en el 75% de los ratones del Grupo I y en el 92% de los del Grupo II. En cambio, los tumores hepaticos aparecieron en el 14% de los ratones que solo fueron irradiados (Grupo V) y en el 2,4% de los expuestos

  19. Incidence du cancer au Canada : tendances et projections (1983-2032

    Directory of Open Access Journals (Sweden)

    Lin Xie

    2015-01-01

    devrait continuer d'augmenter de 2 % entre 2003-2007 et 2008-2012, puis commencer à fléchir de 18 % au cours des 20 dernières années de projection. De tous les cancers féminins, on s'attend à ce que l'incidence du cancer du sein soit celle qui change le moins (une hausse de moins de 1 %. L'évolution prévue des taux pour le cancer colorectal est inférieure aux médianes pour l'ensemble des cancers, avec une diminution de 6 %, tant chez les hommes que chez les femmes, durant toute la période de projection. En ce qui concerne le cancer de la prostate, si la prévalence du dépistage se stabilise à l'avenir, les taux devraient demeurer stables. Augmentation prévue du nombre de nouveaux cas de cancer : Au Canada, on prévoit que le nombre annuel de nouveaux cas de cancer augmentera de 84 % chez les hommes, passant de 80 800 en 2003-2007 à 148 400 en 2028-2032, et de 74 % chez les femmes, passant de 74 200 à 128 800. Facteurs des variations dans les cas de cancer : La principale raison de la hausse du nombre de tous les cas de cancer nouvellement diagnostiqués sera le vieillissement de la population canadienne, et dans une moindre mesure la croissance démographique. Les variations du risque de cancer constitueront une composante relativement mineure de la hausse prévue du nombre de nouveaux cas. Les interventions préventives peuvent grandement influencer les taux d'incidence futurs de certains types de cancer. Cancers les plus courants : Les cancers les plus courants chez les hommes — cancers de la prostate, du poumon et de la vessie, cancer colorectal et lymphome non hodgkinien — devraient demeurer inchangés entre 2003-2007 et 2028-2032, mais on prévoit que le cancer colorectal remplacera le cancer du poumon au deuxième rang des cancers les plus fréquemment diagnostiqués d'ici 2028-2032. Chez les femmes, les cancers du sein, du poumon, de l'utérus ainsi que le cancer colorectal sont les quatre principaux cancers pour lesquels de nouveaux cas seront